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Regulation of Hematopoietic Stem Cell Migration and Function 
 
 
Abstract 
 
 
 Hematopoietic stem cell transplantation (HSCT) is an effective treatment for 
blood disorders and autoimmune diseases. Following HSCT, these cells must 
successfully migrate to the marrow niche and replenish the blood system of the recipient. 
This process requires both non-cell and cell-autonomous regulation of hematopoietic 
stem and progenitor cells (HSPCs).  A transgenic reporter line in zebrafish allowed the 
investigation of factors that regulate HSPC migration and function.  To directly observe 
cells in their endogenous microenvironment, confocal live imaging was used to track 
runx1:GFP+ HSPCs as they arrive and lodge in the niche.  A novel cellular interaction 
was observed that involves triggered remodeling of perivascular endothelial cells during 
niche formation.  A chemical screen identified the TGF-beta pathway as a regulator of 
HSPC and niche interactions. Chemical manipulation of HSPCs was used to improve 
engraftment and repopulation capability following transplantation.  Runx1:GFP fish 
treated with prostaglandin E2 (PGE2) during embryogenesis exhibit increased runx1+ 
cells in the AGM and CHT, consistent with previous in situ data.  This increase in HSPCs 
is maintained into adulthood, even in the absence of prolonged PGE2 exposure.  Kidney 
marrow from these treated fish can outcompete control marrow in transplantation assays.  
The ability of PGE2 to confer a long-term advantage on sorted mouse marrow 
populations in competitive transplantation assays was tested.  I found that PGE2-treated 
  iv 
short-term (ST)-HSCs, but not long-term (LT)-HSCs show enhanced transplantability in 
recipients compared to control animals.  My studies demonstrate that the effects of PGE2 
on HSC function persist over substantial time despite transient exposure.  A population of 
short-term HSCs can engraft and give rise to long-term multilineage reconstitution 
following PGE2 treatment.  Collectively, our studies have led to novel insights regarding 
the pathways involved in HSC migration, homing, and repopulation. 
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 3 
Review 
 Hematopoietic stem cells (HSCs) are a rare cell type with the ability to self renew 
and differentiate.  In addition to maintaining hematopoietic homeostasis, HSCs must 
respond to stress conditions and fluctuate between a quiescent and an actively cycling 
state.  Following HSC transplantation, these cells must successfully migrate to the 
marrow niche and replenish the blood system of the recipient. Although much is known 
about the importance and clinical relevance of HSCs, very little is known regarding the 
mechanisms of HSC function.  Utilizing the zebrafish as a model system has allowed us 
to study novel pathways, identified through chemical screening, involved in HSC 
migration, homing, and repopulation. 
  
Hematopoietic Stem Cells 
 HSCs are a rare cell population with the ability to both self-renew and 
differentiate into all mature blood cells via a life-long process called hematopoiesis1,2,3.  
Vertebrate hematopoiesis occurs in two waves, the primitive wave and the definitive 
wave.  During the primitive wave, erythrocytes and macrophages are produced to help 
oxygenate and remodel the developing embryo.  The definitive wave is marked by the 
emergence of HSCs, which will support the hematopoietic system for the life of the 
organism.  In the mouse, the first long-term HSCs are detected in the aorta–gonad–
mesonephros (AGM) region by embryonic day 10.5 and later colonize the fetal liver, 
thymus, spleen, and bone marrow4.  Key transcription factors that play a role in the 
development of the hematopoietic system include runx1, scl, and c-myb. 
 The bone marrow is composed of a diverse set of cell types, including osteoblasts, 
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endothelial cells, stromal cells, adipocytes, and mature blood cells, which form a 
regulatory environment called the niche5.  HSCs must respond to regulatory signals in the 
marrow niche and either maintain the HSC pool through self-renewal, or produce mature 
blood cells by dividing into progenitor cells.  Through this cellular hierarchy, HSCs are 
able to maintain hematopoietic homeostasis throughout the lifespan of an organism. 
 
Zebrafish Hematopoiesis 
Despite the extensive evolutionary divergence between bony fish and mammals, 
the teleost Danio rerio, more commonly called the zebrafish, remains a robust model for 
studying hematopoiesis.  Genetic pathways regulating hematopoiesis have been 
conserved from zebrafish to mammals, including two distinct waves of hematopoiesis, 
outlined in figure 16.  Zebrafish undergo primitive hematopoiesis in an intraembryonic 
region called the intermediate cell mass (ICM), compared with the extraembryonic yolk 
sac in mammals7.  The primitive wave produces lineage-committed erythroid and 
myeloid progenitor cells, which express specific transcription factors such as gata1 and 
pu.18.  Zebrafish definitive hematopoiesis occurs in the ventral wall of the dorsal aorta, 
the aorta-gonad-mesonephros (AGM) equivalent region in the zebrafish.  Definitive 
hematopoiesis produces all lineages of blood cells and functional HSCs, which express 
transcription factors such as runx1, cmyb, CD41, and lmo29.  The zebrafish equivalent of 
mammalian bone marrow is the kidney, which supports definitive hematopoiesis from 4 
days post fertilization (dpf) through adulthood.  Whole kidney marrow (WKM) 
transplanted into lethally irradiated recipient fish has been shown to rescue recipient fish 
and repopulate all blood lineages.   
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Figure 1.  Spatial and temporal representation of hematopoiesis in the zebrafish 
The primitive wave of hematopoiesis is depicted in yellow and the definitive wave is depicted in blue.  The 
locations of different sites of hematopoiesis are depicted in a 24hpf embryo (left) and a 72hpf embryo 
(right).  The timline for expression of blood-specific markers at different sites of hematopoiesis is shown in 
the bottom panel.   
 
 
 
FACS analysis of whole kidney marrow can be used to analyze the hematopoietic 
system and differentiate cell populations10.  A member of our lab has successfully 
developed a competitive transplant assay system in which the homing and engraftment of 
HSCs into irradiated recipient fish can be assessed using fluorescence microscopy and 
FACS analysis (Figure 2).  Using a transparent fish called Casper, a double mutant in 
pigment genes nacre and roy, allows for easy visualization of the transplanted cell 
populations using fluorescence microscopy11.  This competitive transplant assay allows 
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for analysis of different HSC conditions and their effect on engraftment efficiency during 
WKM transplant. Aside from genetic similarity, the zebrafish has other advantages for 
studying hematopoiesis.  Unlike mammals, zebrafish red blood cells are nucleated, 
making it possible to utilize them in certain experiments such as ChIP and DNase 
hypersensitivity mapping.  Zebrafish embryos are also transparent, which makes it 
possible to view blood circulation with a dissecting microscope12.  In addition, a pair of 
zebrafish can produce 100-200 embryos per week, making them a useful system for 
large-scale chemical and genetic screens.  
 
 
Figure 2. Competitive transplantation and readout schematic 
The diagram on the left is a schematic of competitive transplantation in adult zebrafish.  Marrow cells are 
harvested from GFP+ donor fish and treated with chemical or vehicle.  20,000 treated WKM cells are mixed 
with 80,000 untreated mCherry+ cells and injected into irradiated recipient fish.  Several months following 
transplantation, FACS analysis is performed on WKM of recipient fish.  The graph on the right is a 
representative plot that shows the major blood lineages detectable by FACS.   
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Hematopoietic Stem Cell Niche  
 The bone marrow niche for HSCs is a complex microenvironment that regulates 
hematopoietic stem and progenitor cell (HSPC) function and supports both self-renewal 
and differentiation processes13.  Many interacting cell types and signaling networks exist 
in the niche environment, which have a mixture of direct and indirect effects on HSCs14.  
The niche protects HSCs from cellular stress, particularly by limiting the accumulation of 
reactive oxygen species.  In addition, it is thought that osteoblastic cells help maintain 
HSCs in a quiescent state, which is necessary to prevent excessive proliferation and 
exhaustion, although this effect may not be direct15.  Within the bone marrow, a 
perivascular niche comprised of a network of sinusoidal vessels provides a connection 
between circulating cells and the marrow niche.  It is common for HSCs to localize to 
sinusoids, suggesting that the cell types that surround these vessels play a role in HSC 
maintenance16.  For example, mesenchymal stem cells (MSCs) are found proximal to 
niche blood vessels and express fibroblast activation protein (FAP).  Knock down of 
FAP+ cells results in anemia and hypocellularity in the bone marrow17–19.  Endothelial 
cells in the perivascular niche have also been shown to regulate HSC maintenance both in 
vitro and in vivo, however it is unknown whether this effect is direct or indirect20,21.   
 Although the bone marrow niche is a highly dynamic structure, comprised of 
numerous cell types and signaling networks and closely linked to circulation, our current 
methods of studying this environment are lacking.  Experimental protocols looking at 
fixed sections and sorted cells lack information about the dynamic cellular interactions 
occurring the in the niche space.  In addition, our knowledge about HSC migration to and 
subsequent colonization of the niche remains largely unknown. Understanding these 
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trafficking and engraftment mechanisms is critically important because they are 
mimicked during clinical stem cell mobilization and transplantation.    
 
Hematopoietic Stem Cell Transplantation 
 HSCs are arguably the most studied type of stem cell, and transplantation of 
HSCs has been used in the clinic for several decades as an effective therapy for leukemia, 
lymphoma, blood disorders, and autoimmune diseases1,2.  Hematopoietic stem cell 
transplantation (HSCT) is achieved through transplantation of bone marrow, mobilized 
peripheral blood, or umbilical cord blood-derived HSPCs.  Preconditioning for HSCT 
entails ablation of the recipients’ bone marrow, leaving patients at risk for infection, 
anemia, and thrombocytopenia.  Transplanted HSCs must efficiently home to the niche, 
differentiate, and repopulate the host hematopoietic system.  Recent studies have focused 
on the use of chemicals to enhance collection and transplantation efficiency of HSCs and 
HSPCs in order to shorten engraftment time and diminish risk for myeloablated 
patients22,23.  This effort includes improving HSC expansion prior to transplantation, as 
well as improving the efficacy of HSPC homing and niche interaction following 
transplantation.  One way to test for successful engraftment in patients is to measure 
neutrophil recovery.  Improving this parameter by even a few days could have a dramatic 
effect on patient outcome.  
 
Phenotypic Characterization of HSCs 
  Blood cells are an extremely heterogeneous population comprised of stem cells 
with varying degrees of repopulation activity, multipotent progenitor cells, and fully 
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differentiated cells.  For decades we have been able to study the functionality of these 
cells using elegant in vivo repopulation techniques24.  The gold standard to identify a 
bona fide HSC is to perform bone marrow transplantation and observe multilineage 
reconstitution for at least 6-12 months following transplant.  However, true HSCs are 
very rare amid all blood cells.  In mice only about 1 in 105 bone marrow cells is a long-
term reconstituting stem cell; in humans this number is closer to 1 in 106 cells25.  In the 
past 25 years or so, a significant number of antibody combinations have been developed 
for both mouse and human to distinguish between stem and progenitor cells, and 
differentiated lineages.  Murine HSCs were initially identified as lineage-, Sca1+, c-Kit+ 
(LSK) cells in the bone marrow26.  The Nakauchi lab demonstrated through single cell 
transplantation experiments that LSKCD34- cells give rise to multilineage reconstitution 
in 40% of recipient mice, demonstrating a tremendous improvement in the purification of 
HSCs27.  Similarly, Sean Morrison’s lab identified the signaling lymphocyte activation 
molecule (SLAM) family as a reliable and robust method for isolating HSCs.  SLAM 
family receptors mark a variety of immune cells and are differentially expressed in HSPC 
populations28.  They demonstrated 47% of LSKCD48-CD150+ cells can give rise to long-
term multilineage reconstitution in recipient mice.  Alternatively, progenitor populations 
have been observed that are LSKCD34+Flk2+, or LSKCD48+CD150-, which remain 
multipotent, but have only transient reconstitution capabilities29. 
 In contrast to surface marker characterizations in mouse, almost all human HSCs 
reside in the CD34+ fraction.  Human HSCs are most commonly defined by a 
CD34+Thy1+CD38-CD45RA- phenotype30–32.  However, these markers alone are not 
enough to exclusively distinguish cells with long-term repopulation capacity from those 
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without.  Sophisticated marker combinations allow us to study the functionality of more 
purified populations, as well as the molecular factors that underlie these differences.  This 
is especially useful when studying the heterogeneity of human blood cells, and could 
have important clinical implications for patients receiving HSCT. 
 
Regulation of HSC Homing and Engraftment 
 The cytokine stromal-derived factor 1 (SDF-1) is a strong chemo-attractant for 
CD34+ cells, which express its receptor, CXCR4.  The migration potential of HSPCs 
towards a gradient of SDF-1 has been demonstrated both in vitro and in vivo.  In the bone 
marrow, SDF-1 –expressing stromal cells keep HSPCs in the niche.  Mobilized HSPCs 
have decreased expression of CXCR4, making it an attractive target to manipulate both 
migration and homing33.  During preconditioning for HSCT, SDF-1 levels in bone 
marrow are increased, allowing for enhanced trafficking of HSCs to the niche.  It has 
recently been reported that complement is also activated upon myeloablation, and that a 
specific protein component fragment, C3a, increases the responsiveness of HSCs to SDF-
134.  Mice treated with the small molecule SB290157, a C3a receptor (C3aR) antagonist, 
displayed enhanced mobilization following granulocyte colony signaling factor (G-CSF) 
treatment.  In addition, these cells exhibit impaired engraftment35.  Interestingly, this 
engraftment defect is blocked when C3aR-deficient cells are primed with C3a prior to 
transplantation.        
 Following transplantation, cells must home to the bone marrow niche to 
effectively repopulate the recipient blood system.  Improving homing and engraftment 
efficiency is crucial for the recovery of myeloablated patients.  As mentioned previously, 
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HSCs expressing CXCR4 will migrate towards a gradient of SDF-1 present in bone 
marrow, whereas mobilized HSCs exhibit reduced CXCR4 expression.  This suggests 
that maintaining a functional interaction between CXCR4 and SDF-1 is essential for 
proper homing.  CD26/DPP4 is a membrane-bound extracellular peptidase found on a 
subpopulation of CD34+ cells.  It is known to cleave SDF-1 at the N-terminus and prevent 
its interaction with CXCR4, resulting in decreased migration of these cells to the 
niche36,37.  Treatment of CD34+ cells with Diprotin A, a small molecule inhibitor of 
CD26/DPP4, greatly enhances homing and engraftment following transplantation.  
Similar effects were observed in CD26/DPP4- deficient cells.  This effect is dependent on 
CXCR4, as co-treatment with AMD3100 blocks the effect of Diprotin A treatment on 
homing38. 
 
Umbilical Cord Blood Transplantation 
 Trafficking of HSCs from the bone marrow to peripheral blood, termed 
mobilization, is an important element of maintaining hematopoietic homeostasis.  In 
addition, mobilized HSCs are generally the preferred source of stem cells for autologous 
and allogeneic-donor transplantation.  However, the frequency of steady-state HSCs 
present in peripheral blood at any time during homeostasis is not high enough for 
successful transplantation and engraftment39.  Therefore, prior to transplantation, 
autologous patient and allogeneic donor HSCs are mobilized using chemotherapy or 
cytokines.  Efficient mobilization of HSCs is essential in order to yield enough stem cells 
for HSCT.  G-CSF is commonly used to induce mobilization of HSCs to peripheral blood 
prior to collection.  There are several disadvantages to G-CSF, including a lengthy 
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administration protocol, an unpredictable variable response, and rare but serious side 
effects40.  
 Umbilical cord blood (UCB) has emerged as a promising source of transplantable 
HSCs for patients without a related or immune-matched donor.  Although the stringency 
for HLA-matching is reduced, there are insufficient numbers of HSCs in a single UCB 
unit to engraft an adult patient in the United States.  To compensate, two UCB units are 
given as the standard of care during transplantation (Figure 3)41,42. The ability to expand 
HSCs in culture prior to transplantation has important clinical applications.  Despite a 
growing body of research on the mechanisms governing HSC self-renewal, previous 
attempts at culturing HSCs in vitro while maintaining their stem cell properties have 
failed to generate large numbers in culture.  Expansion of UCB HSCs prior to 
transplantation could potentially reduce the number of UCB units necessary for 
successful engraftment.  Utilizing small molecules to expand HSCs in vitro is particularly 
appealing as chemicals can be removed before cells are introduced to patients. 
  
Prostaglandin E2 
A chemical screen for HSC formation in zebrafish  
 A small molecule screen in zebrafish identified 16,16-dimethyl-Prostaglandin E2 
(PGE2) as a mediator of HSC formation during embryonic hematopoiesis43.  Zebrafish 
embryos treated with PGE2 during embryogenesis displayed increased expression of HSC 
markers runx1 and cmyb in the dorsal aorta.  Expressions of these markers were used as a 
proxy for HSCs as both are expressed in all HSCs and are required for proper HSC 
generation in the AGM region44,45. Endogenous requirement for PGE2 in HSC formation  
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Figure 3. Review of hematopoietic stem cell transplantation  
HSCT is achieved through transplantation of cells derived from the patient, as in autologous transplant.  
Alternatively, a healthy donor marrow or a cord blood unit cells can be used in allogeneic transplant,  
During cord blood transplantation, two cords are required for an adult patient.  HSCs are usually mobilized 
or eliminated prior to transplant.  The transplanted cells must successfully home to and engraft in the niche 
following transplantation. 
 
 
 
was confirmed using morpholino knock out of the PGE2 biosynthetic enzymes Cox-1 and 
Cox-2, resulting in decreased HSCs. Irradiation recovery experiments were used as an 
injury model to demonstrate HSC activation. Treatment with PGE2 enhanced the rate of 
kidney marrow recovery in irradiated recipients compared with control treated animals, 
suggesting PGE2 treatment as a potential therapy to improve the recovery time of 
myeloablated patients. 
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Conservation in mammals 
 The effects of PGE2 on HSCs were tested using murine transplantation assays. 
Bone marrow cells were treated ex vivo with PGE2 and transplanted into irradiated 
recipients to assess either short-term progenitor potential or long-term-HSC function. 
Colony forming units (CFU-Spleen) assays demonstrated that PGE2 enhances HSPC 
activity. Competitive repopulation with limiting dilution analysis showed that ex vivo 
PGE2 treatment increased the number of repopulating HSCs without disrupting 
differentiation. 
A study by Hoggatt et al.46 confirmed enhanced murine HSC engraftment following 
exposure to PGE2, observing a four-fold increase in HSCs up to 20 weeks following 
transplantation. Whole bone marrow (WBM) harvested from primary recipients at 20 
weeks post transplant maintained PGE2-induced enhancement of HSC frequency in 
secondary recipients without additional PGE2 treatment. These findings suggest that 
short-term PGE2 exposure results in a long-term repopulation advantage of transplanted 
WBM. 
 The effects of PGE2 on HSCs could be the result of an increase in HSC number, 
homing capability, proliferation, survival, or a combination thereof. To evaluate the 
homing capabilities of PGE2-treated WBM, labeled cells were transplanted into irradiated 
recipients.  A significant increase in homing of PGE2-treated LSK cells to recipient 
marrow was observed compared with control.   Consistent with the murine LSK 
population, PGE2-treated UCB cells displayed enhanced homing to the marrow. This 
homing effect is partially attributed to an increase in CXCR4 expression following PGE2 
treatment.  PGE2 treatment of murine LSK and human CD34+ cells increased expression 
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of CXCR4.  In addition to its affect on homing, PGE2 increased Survivin, an important 
regulator of HSC survival and proliferation, in LSK and UCB cells following pulse 
treatment.  Further supporting a role in HSC proliferation, SLAM LSK cells treated with 
PGE2 displayed a significant increase in the percentage of cycling cells. 
 Until recently there existed no data for in vivo treatment of PGE2 in the murine 
system.  Frisch et al.47 utilized a continuous in vivo treatment regimen to study the effects 
of PGE2 in mice.  Consistent with previous in vitro data, it was observed that in vivo 
dmPGE2 treatment significantly increased the LSK population without disrupting 
hematopoietic differentiation. To determine which subpopulation(s) in LSK cells are 
directly affected by PGE2, SLAM receptors were used to distinguish the long-term-HSC 
subset from short-term-HSCs and multipotent progenitors (MPPs).  In vivo PGE2 
treatment preferentially increased the short term (ST)-HSC/MPP subpopulation without 
changing the frequency of long term (LT)-HSCs. Consistent with ex vivo treatment 
transplantation assays, transplanted cells from mice treated with PGE2 in vivo 
demonstrated increased engraftment and hematopoietic reconstitution of host animals; 
however, this competitive advantage was eventually lost, most likely due to exhaustion.   
 
PGE2 in clinical trials 
 Human CD34+ cells treated with PGE2 and transplanted into immunodeficient 
mice demonstrate enhanced transplantation abilities.  The number of human CD45+ cells 
detected in the peripheral blood and bone marrow of recipient mice was ~2-fold higher in 
PGE2-treated groups compared to control48.  This data suggested that PGE2 could be used 
to expand UCB cells prior to transplantation.  A phase 1 trial was recently completed to 
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test expansion and subsequent transplantation of UCB HSCs following ex vivo PGE2 
exposure, which included 12 patients and optimized treatment conditions49.  Each patient 
received two cord blood units (CBUs) infused in succession; the first CBU was treated 
with PGE2, the second CBU was untreated.  Neutrophil engraftment was observed in 
100% of patients in the trial, compared to 90% of historic control.  The median time to 
engraftment was 17.5 days versus 21 days, respectively.  PGE2-treated CBU displayed 
enhanced engraftment by outcompeting the untreated CBU in 10 out of 12 patients.  
Initial results demonstrate that this PGE2 treatment regimen is clinically well tolerated.  It 
may be possible in the future to achieve engraftment in patients receiving only a single 
CBU that is expanded with PGE2.  Collectively, these studies have clearly defined a role 
for PGE2 in the function of HSPCs, yet the mechanisms behind its effects remain largely 
unknown. 
 
Synthesis and mechanism of action 
 Prostaglandins are lipid compounds of the eicosanoid family that play a major 
role in inflammatory and immune response as well as various other tissue responses50,51. 
They are found in a majority of tissues and are produced by a number of cell types.  
When synthesized, prostaglandins function locally as autocrine or paracrine lipid 
mediators.  Prostaglandins are derived from arachidonic acid, which is oxidized by Cox-1 
and Cox-2 to form PGG2.  PGG2 is subsequently reduced to PGH2, from which all three 
classes of prostaglandins originate.  Prostaglandin E synthase acts on PGH2 to produce 
PGE252. Cox-1 is constitutively expressed in most tissues, whereas Cox-2 is silenced in 
normal physiological conditions but can rapidly activate downstream targets during times 
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of stress. 
 PGE2 acts via four G-protein coupled E-prostanoid receptors PTGER1-4 (EP1-4), 
resulting in various and sometimes opposing downstream effects53. PGE2 has been shown 
to be both a vasodilator (in arterial and venous beds) and a vasoconstrictor (in the trachea 
and intestine), supporting evidence of multiple functional E-prostanoid receptors54. These 
receptors are loosely classified based on their function as relaxants or constrictors of 
smooth muscle cells. EP2 and EP4 are relaxant receptors and result in production of 
cAMP upon binding of PGE2.  Despite this common pathway, additional unique 
functions have been shown for each receptor.  PGE2 bound to EP2 but not EP4 can result 
in activation of the EGF receptor leading to increased invasion of colon cancer cells.  EP1 
receptors are constrictors, where binding of PGE2 increases intracellular calcium levels in 
smooth muscle cells. The diverse effects of PGE2 signaling are further demonstrated 
through EP3 receptor activity. Different splice variants of EP3 receptors have been 
implicated in cAMP induction and inhibition, as well as generation of IP3. In addition, 
PGE2 binds E-prostanoid receptors with different affinities, with a higher affinity for EP3 
and EP4, and a lower affinity for EP1 and EP255. 
 In zebrafish, the PGE2 receptors expressed on HSCs are Ptger2 and Ptger4.  
Knock down of ptger2 or ptger4 results in a decrease of runx/cmyb expression in the 
AGM that is not rescued with PGE2 treatment43.  This suggests that PGE2 signals through 
Ptger2 and Ptger4 to regulate HSC formation in zebrafish embryos.  Interestingly, 
binding of PGE2 to EP2 or EP4 can lead to activation of GSK-3/!-catenin signaling 
pathway via protein kinase A and phosphoinositide 3-kinase, respectively56.  
Furthermore, a recent study demonstrated an in vivo conserved genetic interaction 
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between PGE2 and Wnt at the level of the !-catenin stabilization in the zebrafish57.  PGE2  
treatment significantly increases expression of a !-catenin responsive GFP reporter in the 
AGM region, while treatment with indomethacin, a non-selective COX inhibitor, 
decreased expression.  Co-localization of the GFP reporter and lmo2 indicated Wnt 
activity was present in HSCs and endothelial cells of the dorsal aorta.  Induction of Wnt 
signaling during embryogenesis increased runx1+ cells in the AGM, however treatment 
with indomethacin blocked this increase, suggesting PGE2 is required for this effect.  A 
zebrafish cmyb:GFP reporter line was used to demonstrate that PGE2 and Wnt signaling 
synergize to increase HSC number in the AGM.  Combined treatment of PGE2 and Wnt 
activation enhanced the effect of Wnt activation alone.  These results suggest that PGE2 is 
required for Wnt-mediated effects on HSC development and can enhance Wnt activity in 
vivo.    
 PGE2 and Wnt interaction was tested in the adult zebrafish using a kidney marrow 
recovery assay.  FACS analysis of recovering marrow indicates that Wnt activation 
significantly increased HSPC population and this was blocked by indomethacin.  These 
results support interplay of PGE2 and Wnt signaling in the adult zebrafish.  To determine 
whether this interaction is conserved in mammals, purified LSK cells were transplanted 
into irradiated mice.  Recipients were treated with 6-bromoindirubin-3’-oxime (BIO), a 
GSK3! inhibitor, indomethacin, or both.  CFU-S assays following treatment 
demonstrated an increase in progenitor cells after BIO treatment; this effect was reduced 
to baseline levels upon treatment of indomethacin, demonstrating that PGE2 mediates 
Wnt activity on mammalian hematopoietic progenitor cells.   
 19 
 All 4 EP receptors are expressed on murine progenitor populations (LSK) as well 
as more purified stem cell populations (LSKCD48-CD150+).  EP1-EP4 receptors are also 
found on human CD34+CD38- cells46.  This data, combined with the observed genetic 
interaction between PGE2 and Wnt, suggests the EP2 and EP4 receptors in particular 
might play an important role in the regulation of HSCs. 
 Knockdown of EP4 in LSK cells results in decreased repopulation ability 
following transplantation, as well as a skewing towards T cell and myeloid lineages 
during differentiation58.  In contrast, EP2 knockout mice exhibit normal hematopoiesis, 
reconstitution capabilities, and differentiation.  In addition, treatment of LSK cells with 
an EP4 agonist, but not an EP2 agonist, lead to an increase in phosphorylation of GSK3! 
and !-catenin.  Co-treatment of a PKA inhibitor with PGE2 blocked the activation of 
GSK3!.  This data suggests that PGE2 acts through EP4 to activate the cAMP/PKA 
pathway in HSPCs.           
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Thesis Review 
 In this thesis we have used zebrafish and mouse models to study the endogenous 
microenvironment and trafficking of HSPCs in the niche.  We have also studied the long-
term repopulating capabilities of PGE2-treated HSPCs following transplantation.  To 
accomplish this, we developed a novel zebrafish transgenic reporter line that enabled us 
to visualize and purify zebrafish HSPCs.  We demonstrate that the runx1:GFP labels a 
population of stem and progenitor cells in zebrafish close to that of LSK in mice.  We 
used this line to observe a novel and essential cellular behavior that involves triggered 
remodeling of perivascular endothelial cells upon arrival of an HSPC in a new site of 
hematopoiesis.  A chemical screen during zebrafish embryogenesis revealed novel 
compounds that regulate cellular behaviors, such as adhesion and division, in the CHT.  
Imaging of fetal liver explants revealed that our observed endothelial niche remodeling is 
conserved in mammals. 
 Runx1:GFP fish treated with PGE2 during embryogenesis exhibit increased 
runx1+ cells in the AGM and CHT, consistent with previous in situ data.  This increase in 
HSPCs is maintained into adulthood, even in the absence of prolonged PGE2 exposure.  
Kidney marrow from these treated fish can outcompete control marrow in transplantation 
assays.  This advantage appears to be due to an effect on the HSPC pool as a whole, 
rather than an individual cell basis.  The long-term effect of PGE2 on HSCT is conserved 
in mammals; WBM cells treated with PGE2 maintain increased chimerism levels in 
recipient mice over 1-year post transplantation.  These cells display enhanced 
transplantability in competitive secondary transplantations without additional PGE2 
treatment.   
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 Further purification of murine HSPCs using cell surface marker antibody 
combinations demonstrated that PGE2 affects a specific population of HSCs that are 
phenotypically LSKCD48-CD34+CD150+.  Historically thought to only have transient 
multilineage potential, we show that following PGE2 treatment these cells display long -
term multilineage reconstitution that persists at least 1-year post primary transplant.  
Gene expression data and ChIP-seq analysis in human CD34+ cells suggests that PGE2 
may play a role in the quiescent state of these cells.   
 Our studies provide a glimpse into the dynamic interactions between HSPCs and 
their endogenous niche.  In addition, we show that a population of short-term HSCs can 
engraft and give rise to long-term multilineage reconstitution following PGE2 treatment.  
Collectively, we have gained novel insights in the pathways involved in HSC migration, 
homing, and repopulation. 
 
   
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
Chapter 2 
 
Live imaging of hematopoietic stem cell lodgement reveals  
dynamic endothelial niche remodeling 
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Attributions 
 This chapter is to be submitted as a co-first author paper with Owen Tamplin, a 
post-doctoral fellow in the lab.  Owen established the Runx1:GFP and Runx1:mCherry 
transgenic zebrafish lines.  I characterized these lines by designing and performing all 
FACS experiments to detect Runx1+ cells in embryonic and adult zebrafish and compared 
the new Runx1 lines to previously used HSPC zebrafish lines.  I also designed and 
performed the limit dilution transplantations in adult fish and performed FACS analysis 
on embryonic transplants.  Owen performed all confocal microscopy and time-lapse 
movies using the Runx1 transgenic lines.  EM microscopy was done by Sarah Childs at 
Alberta Children’s Hospital Research Institute, University of Calgary.  Owen performed 
the chemical screen in zebrafish embryos.  I established a FACS protocol to study the 
effect of Lycorine on Runx1+ cells and designed and performed the experiments for 
microarray on Lycorine-treated cells.  We both designed experiments for studying murine 
fetal liver HSCs.  Owen performed microscopy for fetal liver explants, and I 
characterized these cells and performed the FACS analysis/sorts. 
 The addendum to this chapter includes work done in the mouse system to further 
study the interactions between the CXCR4 and S1P signaling pathways during 
mobilization and homing that is not included in the publication.  Owen designed and 
performed the chemical screen in zebrafish that identified a role for the S1P pathway in 
CHT engraftment, as well as optimized dose response and interactions with CXCR4 in 
the zebrafish.  I designed and performed all mouse experiments, including treating cells 
and FACS analysis, mobilization, and homing experiments.  
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Abstract 
  Hematopoietic stem and progenitor cells (HSPCs) are able to reconstitute and 
sustain the entire blood system, making them critical for clinical transplantation as a 
treatment for leukemia and blood disease.  To directly observe HSPCs in their 
endogenous microenvironment, we established a highly specific transgenic reporter in the 
zebrafish.  Using confocal live imaging to track an HSPC as it arrives and lodges in the 
perivascular niche, we observed a novel cellular interaction—a small group of endothelial 
cells remodel around a single HSPC to form a surrounding pocket. To resolve the 
ultrastructure of this niche, we correlated live imaging of these rare cellular events with 
high-resolution 3D scanning electron microscopy data.  Endothelial niche formation 
triggered by HSPC arrival is evolutionarily conserved in the mouse fetal liver. A 
chemical screen identified small molecule regulators of HSPC niche colonization.  Our 
work establishes a new dynamic model of niche formation during stem cell engraftment. 
 
Introduction 
 Hematopoietic stem and progenitor cells (HSPCs) self-renew and give rise to all 
blood cell types. During development and throughout adulthood, HSPCs will undergo 
many migration events. Definitive HSPCs arise from the hemogenic endothelium of the 
dorsal aorta (DA)59–61 are released into circulation, and then seed an intermediate 
hematopoietic niche before colonizing the adult marrow. In mammals, this intermediate 
tissue is the fetal liver (FL), and in zebrafish it is the caudal hematopoietic tissue (CHT), 
a vascular plexus in the ventral tail of the embryo62,63. After rapid expansion in the 
intermediate niche, HSPCs will leave and go on to seed the adult marrow, which in 
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mammals is bone and in zebrafish is kidney64.  During life the changing requirements for 
HSPCs in the marrow and other tissues of the body dictate that stem cells continue 
migrating between different locations65.  HSPC trafficking during development and in the 
adult is highly regulated, enabling release of stem cells into circulation, followed by 
homing and engraftment into a niche. Understanding these trafficking mechanisms is 
critically important because they are mimicked during clinical stem cell mobilization and 
transplantation. 
 
 The HSPC niche is a complex microenvironment that maintains the stem cell pool 
throughout life, while balancing the production of multilineage progenitors. It has been 
thought that the endosteum of the bone marrow and its osteoblastic cells create a unique 
region that favors HSPC quiescence15.  The bone marrow also contains a complex 
network of sinusoidal vessels that act as an interface between circulation and the niche. In 
fact, most HSPCs are proximal to these vessels and are therefore considered to be in a 
perivascular niche28,66,67. Studies have shown that endothelial cells (EC) have distinct 
properties that enable them to support and expand associated HSPCs68,69. However, there 
are many different cell types, such as perivascular mesenchymal cells, stromal cells, and 
arterioles that also play a role in the niche67,70,71.  Together these studies build a model of 
the many interacting cell types and signals that make up the HSPC niche 
microenvironment. Yet the static images we have acquired from fixed samples do not 
give us a dynamic view of the interactions between endogenous cell types in the niche. 
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 Live imaging of the adult HSPC niche is a challenging task. Homing of 
circulating HSPCs to the adult bone marrow has been observed in a number of elegant 
studies72–76.  These studies have been technically limited to multiphoton intravital 
microscopy of surgically accessed bone, such as the skull, or bone explants such as the 
femur. There has been the caveat that labeled, sorted and transplanted HSPCs could differ 
physiologically from endogenous HSPCs. Also, in the case of myelosuppressed recipients 
there can be significant damage to the perivascular niche69.  In the embryo, confocal 
time-lapse microscopy has been used to capture the emergence of HSPCs from the 
hemogenic endothelium of the DA in both mouse explants and live zebrafish embryos59–
61, but the immigration of HSPCs into secondary sites of colonization has not been 
extensively studied. 
 
 The zebrafish embryo is particularly amenable to live imaging studies. Here we 
sought to develop a novel transgenic zebrafish that we could use to follow HSPCs during 
migration. Definitive hematopoiesis progresses quickly in the zebrafish: HSPC birth in 
the DA, migration to the CHT, seeding of the thymus, and colonization of the kidney 
marrow takes only five days62.  Conserved hematopoietic regulatory genes have led to the 
development of HSPC transgenic reporter lines, although none of these are entirely 
specific (e.g. cmyb:EGFP, cd41:EGFP77, and runx1P2:EGFP78). To establish a more 
specific HSPC line, we utilized a regulatory element from the first intron of the mouse 
Runx1 locus that is +23 kb downstream of the ATG in the first promoter to drive 
expression of a reporter79.  In mouse, the Runx1+23 enhancer drives early expression in 
the primitive wave of hematopoiesis, then in the definitive wave from HSPC birth in the 
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DA to long-term repopulating hematopoietic stem cells (LTR-HSC) in adult bone 
marrow. We used the Runx1+23 enhancer from mouse to establish a novel HSPC-specific 
transgenic line in zebrafish. The ability to track endogenous HSPC in the live embryo 
allowed us to observe dynamic interactions with other cell types in the niche. We have 
discovered a novel and essential cellular behavior that involves triggered remodeling of 
perivascular EC upon arrival of an HSPC in a new site of hematopoiesis. Using 3D 
reconstruction of high resolution serial section electron microscopy scans, we have an 
accurate view of the stem cell and the adjacent cells in the niche.  Furthermore, we have 
shown that a similar event occurs in the mouse FL, suggesting this is a highly conserved 
step during lodgement of an HSPC in its niche. 
 
 
Materials and Methods 
Zebrafish maintenance and lines 
 Zebrafish and mice were maintained in accordance with Animal Research 
Guidelines at Children's Hospital Boston. Transgenic zebrafish lines were crossed and 
selected by fluorescent microscopy. Time-lapse live imaging was performed using a 
spinning disk confocal with an incubated chamber and moving XY stage. Zebrafish 
embryos and mouse embryo explants were mounted and imaged as previously 
described59,80. We screened a chemical library of ~2400 known bioactive compounds at 
concentrations optimized for whole embryo treatments. After treatment, we checked for 
secondary defects (e.g. stopped circulation, toxicity, developmental delay). Next, we 
performed WISH with HSPC markers cmyb and runx1 as previously described81. 
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Imaging 
 Staged transgenic zebrafish embryos were selected and mounted for imaging in 
1% LMP agarose with E3 media and tricaine as described.  Some zebrafish embryos had 
0.003% PTU (1-Phenyl-2-thiourea) added to the media to block melanogenesis. Zebrafish 
embryos and FL explants were imaged in MatTek glass bottom dishes or multi-well 
plates (No. 1.5 cover slip). Zebrafish live imaging was performed in an incubated 
chamber at 28°C. Mouse embryo explant live imaging was performed in an incubated 
chamber at 37°C with humidified CO2 with culture media (DMEM, 20% FCS, glutamine, 
sodium pyruvate, 2-mercaptoethanol, 1% penicillin-streptomycin, recombinant mouse IL-
3 (R&D Systems; final concentration 50 ng/ml)). Confocal microscopy was performed 
using a Yokogawa spinning disk and Nikon inverted Ti microscope. Our microscope 
configuration allowed imaging of multiple embryos within a 2-5 minute interval using a 
moving XY stage, as well as acquisition of z-stacks through the entire CHT (1-2 µm 
optical slices) in multiple fluorescent channels. Objectives lenses (Nikon): 20x Plan-Apo 
DIC N.A. 0.75; 40x Plan-Apo phase N.A. 0.95 dry; 40x Apo LWD WI NA 1.15 lambda 
S. Image acquisition was done with a single Andor iXon DU-897 EM-CCD camera 
(512x512 pixels) or dual Andor iXon x3 EM-CCD cameras (512x512 pixels) and Andor 
iQ or NIS-elements computer software. Fixed transgenic zebrafish embryos were scanned 
using a Nikon C2si confocal system and NiE upright microscope. These embryos were 
briefly fixed for 10 minutes with PEM fixation buffer (dH20, EGTA 10 mM, MgSO4 1 
mM, PIPES 100 mM, Triton X-100 0.1%, PFA 4%; Cold Spring Harbor Protocols, 2009, 
doi:10.1101/pdb.rec11730), then washed and mounted with DRAQ5 (1:500) for staining 
of nuclei. 
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Imaging analysis 
 Image processing and rendering was done using Fluorender, Imaris (Bitplane), 
NIS-elements (Nikon), Volocity (PerkinElmer) and ImageJ/Fiji. The MTrackJ plugin was 
used for manual cell tracking. Lineage trees were created using Endro. Point-to-point 
measurements were made with Imaris. Manual tracing, segmentation, and surface 
rendering of objects was performed using Imaris. Confocal z-stack images are presented 
as single slices, maximum projections, or 3D rendered projections. In some cases, 
background subtraction was performed, and brightness and contrast was adjusted in one 
or more channels of a multi-channel image. 
 
Immunohistochemistry of adult WKM 
 Adult zebrafish were fixed with 4% paraformaldehyde, paraffin-embedded, 
sectioned, and stained with hematoxylin and eosin (H&E). Immunohistochemistry was 
performed using anti-GFP monoclonal antibody (clone JL-8). The Dako Mouse Envision 
kit with EDTA antigen retrieval was used for visualization. Incubation in the primary 
antibody was 60 minutes, and 30 minutes in the secondary, followed by DAB 
development for 5 minutes and counterstained with hematoxilyn. 
 
Adult-to-Adult HSPC Transplantation 
 WKM cells from 3-month Runx1:mCherry;ubi:GFP fish were isolated and sorted 
by FACS.  Double-positive cells were transplanted into irradiated casper recipients 
(n=20-48 recipients per cell dose) along with untreated helper marrow at the following 
ratios: 1:20,000; 5:20,000; 10:20,000; 25:20,000; 50:20,000. Transplantation procedures 
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were performed as previously described82.  At 3 months post-transplant, WKM from 
recipient fish was collected and analyzed by FACS to detect chimerism levels of 
mCherry and GFP-positive cells in the marrow.  We confirmed multi-lineage 
reconstitution by observing differentiated GFP-positive cells in multiple cell populations, 
as determined by forward and side scatter profiles. Stem cell frequency was determined 
using ELDA software (confidence interval=0.95). 
 
Embryo-to-Embryo HSPC Transplantation 
 Adapted from previously published protocols10,83. Runx1:mCherry;ubi:EGFP or 
Runx1:GFP;ubi:mCherry 3 dpf embryos were collected and chopped finely with a razor 
blade. Embryos were dissociated in a 1:65 dilution of Liberase TM (Roche) in PBS, 
incubated at 37°C for 20 minutes before addition of PBS/5% FCS to stop the reaction. 
Dissociated cells were passed through a 45 µM filter, spun, and resuspended in PBS/5% 
FCS. mCherry+/GFP+ cells were collected using a FACSAria cell sorter (BD 
Biosciences). Collected cells were resuspended in PBS at an estimated concentration of 
400 cells/microliter with 0.5% rhodamine-dextran(10k) as a marker for injection. A 
microinjection needle (without filament) was back-filled with the cell suspension. The 
drop volume was calibrated to 1 nanoliter and each embryo was injected with 1, 2, or 4 
drops. This gave an estimated cell dose of 0.4, 0.8 or 1.6 cells per embryo. Drops were 
injected into the sinus venosus (i.e. duct of Cuvier) of 48 hpf wild-type AB embryo 
recipients. Embryos were held in place using agarose injection ramps. Approximately 30 
embryos were injected per dose and 12-26 embryos per group survived to adulthood (3-5 
months). WKM was then analyzed for percentage of engrafted Runx+ cells using a LSR 
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II flow cytometer (BD Biosciences). Any recipients with positive cells detected above 
background were scored as engrafted. Flow cytometry data was analyzed using 
FACSDiva and FlowJo software. 
 
Serial block face scanning electron microscopy and 3D reconstructions 
 Immediately at the end of live imaging time-lapse acquisition 60 hpf embryos 
were fixed in 2.5% glutaraldehyde and 4% paraformaldehyde in a 0.1 M sodium 
cacodylate buffer. Embryos were embedded in 5% low melting point agarose in 0.1M 
sodium cacodylate buffer for orientation. Samples were submitted to Renovo Neural Inc 
(Cleveland, USA) for further processing. Samples were stained with heavy metals 
following the protocol from the National Center for Microscopy and Imaging Research; 
http://ncmir.ucsd.edu/sbfsem-protocol.pdf. Samples were embedded in Epon resin, and 
mounted onto pins (detailed protocol available from Renovo Neural). Serial blockface 
images (analogous to serial sectioning) were obtained using a Zeiss Sigma VP scanning 
electron microscope equipped with a Gatan 3View in-chamber ultramicrotome. A series 
of 500-1000 images were acquired at 2 kV using at 15,000 magnification from the region 
of interest. Image and stack resolution was 10 nm/pixel with 100 nm slices. Images were 
registered and resized as necessary using ImageJ/Fiji software.  Images were imported 
into the program IMOD 4.5 then aligned and reconstructed using dual-axis tomography. 
Cells were manually outlined and 3D reconstructions were generated. Movies were 
rendered using IMOD and Fiji. 
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Microarrays 
 Runx1:GFP;kdrl:RFP embryos were collected and raised in E3 media at 28.5C. 
Embryos were treated from 2-3 dpf with E3/1% DMSO or E3/1%DMOS/75 uM Lycorine 
(~100-150 embryos per group). Embryos were dissociated and sorted as above. Three 
populations were collected: GFP+ HSPC (~1-2k cells/experiment), RFP+ EC (~10-20k 
cells/experiment), and negative cells (~100k cells/experiment; total embryo as a 
comparator population). In total, 18 samples were collected: 3 biological replicates x 2 
treatment conditions x 3 cell populations. Cells were sorted directly in Trizol LS. Trizol 
extraction was performed as per the manufacturer's instructions, with the addition of 
GenElute LPA (Sigma, Cat.#56575). Total RNA was amplified and labeled using the 
NuGEN Ovation Pico WTA System V2 and Encore Biotin Module kits, respectively. 
Affymetrix ZebGene-1_0-st microarrays were hybridized, washed, and stained using 
Ambion kits. Microarrays were scanned using the Genechip Scanner 3000 7G. 
 
Fetal liver preparations 
 Live fetal liver explants:  Pregnant wild-type C57/BL6 and Ly6a-GFP mice were 
dissected at E11-11.5 (vaginal plug observation was E0). Embryos were removed from 
the uterus in PBS with 10% FCS and penicillin-streptomycin. Embryos were staged as 
E11-E11.5 by counting >42 somite pairs. FLs were removed from the embryo and treated 
as described by Boisset and colleagues (“protocol b”). Conjugated antibodies used for 
detection were CD31-FITC (PECAM-1, BD Biosciences, Rat anti-mouse, clone MEC 
13.3) and c-kit-APC (CD117, BD Biosciences, Rat anti-mouse, clone 2B8). 
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 Fixed fetal livers:  Embryos were dissected as above and fixed in 2% PFA on ice 
for 20 minutes. Embryos were then rinsed and dehydrated in methanol. FLs were 
removed, mounted, cleared and imaged using the method by Yokomizo et al. Livers from 
E11.5 Ly6a-GFP mice were stained with rat anti-CD144, rabbit anti-RUNX1, and 
chicken anti-GFP. Primary and secondary antibody details are below. Specimens were 
scanned using a Zeiss LSM 710 confocal microscope with a 25x oil objective. Images 
were acquired using multi-track sequential mode and Zeiss Zen software. Pinhole was set 
at 1 Airy unit, steps were 1.14 "m per z-section. 3D projections were made using 
Volocity software. 
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Results 
Establishment of a highly specific HSPC transgenic zebrafish line 
 To observe and study endogenous HSPC, we established a transgenic zebrafish 
line with the mouse Runx1+23 enhancer driving either cytoplasmic EGFP (Runx:GFP) or 
nuclear localized mCherry (Runx:mCherry). These two lines were crossed to demonstrate 
that the green and red fluorescent proteins marked the same cell populations (Figure 
S1A). Time-lapse live imaging showed that Runx+ cells emerge from the hemogenic 
endothelium of the DA (Figure S1B and Movie S1). Intercrossing the Runx:mCherry line 
with cmyb:EGFP and cd41:EGFP lines showed that Runx+ cells marked an overlapping 
population of HSPC in all major hematopoietic sites of the embryo, including the DA, 
CHT, thymus and kidney (Figure S1C-L and data not shown). We detected Runx:GFP+ 
cells in the adult kidney marrow using anti-GFP immunohistochemistry and 
fluorescence-activated cell sorting (FACS; Figure S1M-P).  
 Next, we followed HSPCs after their emergence, when they travel through 
circulation to arrive in and seed the CHT niche. At the early stages of FL colonization in 
mouse at embryonic day (E) 11 it is estimated there is only about one transplantable 
HSPC84, predicting that the number of Runx+ cells in the CHT would be rare. We 
quantified the number of Runx:GFP+ cells in the CHT at different developmental stages. 
We found there were only an average of 1, 2, or 5 Runx:GFP+ high cells (and 2, 6, or 10 
Runx:GFP+ low cells) in the CHT at 48, 58, and 80 hpf, respectively (Figure 4A-F). Cell 
numbers in the Runx:mCherry line were comparable, except from 72 hpf there was a 
greater number of Runx:mCherry+ low cells that are likely progeny (Figure S1G-L). 
Looking at Runx:GFP+ cells in the CHT together with a vascular transgenic reporter 
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(kdrl:RFP85 or kdrl:Hsa.hras-mCherry) we found that HSPC were closely associated with 
the EC of the caudal vein plexus (Figure 4A-C). 
 To further understand the association of Runx+ cells with the CHT niche, we 
crossed the Runx:GFP and cxcl12a:DsRed2 transgenic lines to observe HSPC together 
with stromal cells86.  To quantify the proximity of these two cell types within 3D 
confocal z-stacks, we measured the distance between a Runx+ HSPC and its nearest 
cxcl12a+ stromal cell (Figure 4G-I). This analysis showed that 60% of HSPC are in 
contact with a cxcl12a+ cell and 85% are "3 microns distance away. We performed time-
lapse live imaging of CHT colonization in these double transgenic embryos and found 
that arrival and expansion of most HSPC occurred in close proximity to stromal cells 
(data not shown). This provided further support that cxcl12a+ cells are an important 
component of the CHT microenvironment. We confirmed that endothelial and stromal 
cells are closely associated in the CHT62, similar to the perivascular niche in fetal and 
adult bone marrow67,87, and showed that cxcl12a+ cells are distributed in abluminal 
spaces that underlie kdrl+ EC (Figure 4J). The HSPC-specific transgenic line, together 
with endothelial and stromal markers, has allowed us to demarcate HSPCs and their niche 
in the developing zebrafish embryo. 
 
The functional stem cell characteristics of Runx+ HSPC in the zebrafish 
 To assess the functional characteristics of cells in the Runx+ pool, we performed 
limiting dilution transplantation as a standard assay to determine hematopoietic stem cell 
content. We purified Runx:mCherry+ cells from the kidney marrow of adult transgenic 
donors.  These donors also carried the ubiquitous ubi:GFP transgene88 so that  
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Figure 4. A novel transgenic zebrafish line specifically marks HSPC in the CHT niche 
(A-C) The CHT is colonized by Runx:GFP+ HSPC (green) that are closely associated with kdrl:mCherry+ 
EC (red). The caudal artery (CA) is dorsal to the CHT, and the caudal vein (CV) is ventral, with circulation 
running posterior (arrow right) and anterior (arrow left), respectively. A cluster of 3 Runx:GFP+ high cells 
are outlined with a dashed line and 4 Runx:GFP+ low cells are indicated with arrowheads. 58 hpf embryo. 
(D-F) The number of Runx:GFP+ high and low cells are quantified, together with the length of the CHT as 
an indicator of stage. (G) Percentage of HSPCs in the CHT scored by distance to the nearest stromal cell 
(n=168 total cells from 25 embryos). (H) Detail of Runx:GFP+ HSPCs (green) in proximity to 
cxcl12a:DsRed2+ stromal cells (red). Arrowheads mark HSPCs in contact with stromal cell. Circle marks 
HSPC with a 2 µm gap between it and the stromal cell. 60 hpf embryo. (I) cxcl12a:DsRed2+ stromal cells 
(red) underlie kdrl:GFP+ EC (green). 40 hpf embryo. Note: Confocal images are 3D rendered depth 
projections of 20-30 µm z-stacks. Scale bars: (A,I) 25 µm; (H) 10 µm. See also Figure S1. 
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multilineage contribution could be assessed if the Runx:mCherry HSPC enhancer was 
down-regulated upon differentiation. Sorted double positive cells were diluted in a range 
between 1 and 50 then transplanted into irradiated recipients.  Survival rates improved in 
recipients that received a greater number of donor HSPCs, and at 3 months post-
transplantation the kidney marrow of recipients was dissected for FACS analysis. 
Runx:mCherry+ cells were present in the kidney marrow and had contributed ubi:GFP+ 
progeny to all lineages (Figure S2A). Statistical analysis of engraftment over a range of 
cell doses estimated a stem cell frequency of approximately 1/35 (Figure 5).  We consider 
this to be an underestimate because the donors and recipients are non-isogenic, and are 
therefore not immune matched, leading us to assume that some donor cells would be 
rejected. The Runx+ HSPC pool can be sorted with a single transgenic marker, and no 
additional labeling of cell surface markers, to a purity that is within the range of the well-
characterized KSL (c-Kit+ Sca-1+ Lin-) population in mouse89.  Based on the ability of a 
small number of adult Runx+ cells to engraft long-term, self-renew, and produce all 
lineages, we have demonstrated there is substantial stem cell content within this pool of 
cells. However, there are no antibodies available in zebrafish to further purify this 
population, or to distinguish between a stem cell and a progenitor. Therefore we will 
continue to use the term HSPC to describe the Runx+ cells in this study. 
 We also wanted to evaluate the stem cell characteristics of the Runx+ population 
in the embryo. A number of studies have shown that hematopoietic stem cells isolated 
from different tissues of the mouse embryo have the capacity to reconstitute 
hematopoiesis in the adult84,90,91.  However, technical limitations in mouse have made it 
difficult to assess the stem cell potential of an HSPC transplanted from one  
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Figure 5. Runx+ cells in the adult and embryo are functional HSPC 
 
Summary of results from (A) adult-to-adult and (B) embryo-to-embryo limiting dilution transplantation 
experiments. (C) Embryo-to-embryo transplantation recipients with engraftment of Runx:GFP+ cells in the 
kidney marrow at 3 months (above background; >0.001%). Representative kidney marrow FACS plots of 
(D) an adult-to-adult transplantation recipient with Runx:mCherry+ HSPC and ubi:GFP+ lineages, and (E) 
embryo-to-embryo transplantation recipient with Runx:GFP+ HSPC and ubi:mCherry+ lineages. See also 
Figure S2. 
 
 
embryo to another. Based on a previous approach83 we have further developed an HSPC 
transplantation assay that is unique to zebrafish.  HSPCs are sorted from a pool of double 
transgenic Runx+ and ubi+ donor embryos that were 3 dpf. Only 1-2 cells were injected 
into the circulation of a wild-type recipient embryo at 2 dpf. A dilution series established 
the number of cells injected for each experiment.   
 At 2 dpf the CHT is being colonized by endogenous HSPCs but the thymus has 
not formed, allowing introduction of exogenous cells without the possibility of immune 
rejection. Recipient embryos are then raised to adulthood and their kidney marrow is 
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FACS analyzed for engraftment at 3-5 months. We scored engraftment as any detectable 
Runx+ cells above background (Figure 5 and Figure S2). This rationale was chosen 
because approximately one donor HSPC will be competing with endogenous stem cells in 
an unconditioned wild-type recipient embryo, and there is no precedent to predict 
chimerism in this scenario. The transplanted cells must seed the CHT, migrate to the 
kidney, and persist into adulthood where they will self-renew and contribute to all 
lineages. We identified recipients with Runx+ HSPCs and ubi+ progeny in the kidney 
marrow, as well as some that had ubi+ cells in the peripheral blood (Figure S2 and data 
not shown). Statistical analysis estimated the stem cell frequency of the Runx+ 
population in the 3 dpf embryo to be approximately 1/2.88 cells (Figure 5 and Figure S2). 
 These results were representative of three independent experiments—two with 
Runx:GFP;ubi:mCherry double transgenic lines and a third with the opposite 
Runx:mCherry;ubi:GFP transgenic combination. Together, our limiting dilution 
transplantation in adults, as well as our novel embryo transplantation assay, demonstrates 
that Runx+ cells mark a highly purified HSPC population with functional stem cell 
characteristics. 
 
Dynamic visualization of stem cell colonization of the CHT niche 
 To directly observe the interaction of HSPCs with surrounding EC during CHT 
colonization, we performed time-lapse live imaging with spinning-disk confocal 
microscopy. We were able to routinely acquire image series with high temporal 
resolution (1-2 minutes per 2-channel confocal z-stack) for up to 16 continuous hours. A 
widefield image was acquired using a 20x objective because the rare lodgement of a 
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single HSPC could occur anywhere in the length of the CHT (Figure 4A). We observed 
HSPC arrival in the CHT via circulation, followed by adherence to endothelial walls 
(Figure S3A and Movie S2). Next, cells underwent rapid extravasation to the abluminal 
side of the endothelial wall (<5 minutes; Figure S3A). Once HSPCs lodged in the CHT, 
we made a striking and novel observation: a small group of EC actually remodeled 
around a single HSPC to form a stem cell pocket, which we call “endothelial cuddling” 
(Figure 6A and S3B). Within the 12-16 hour limit of time-lapse acquisition, an HSPC 
would make one of three cell division decisions: symmetric, asymmetric, or no division. 
In this example the division is asymmetrical, with one daughter cell crawling out of the 
endothelial niche and the other remaining (Figure S3C). 
 After HSPC lodgement in the CHT, we used higher magnification (40-60x) to 
better detail the close association and contact of surrounding ECs (Figure 6B). To 
quantify the number of surrounding ECs, we briefly fixed and stained embryos with a 
nuclear dye, then imaged using scanning confocal microscopy (Figure 6C). The ECs in 
contact with a single HSPC were outlined with membrane-bound mCherry and their 
nuclei were counted. In each pocket we typically observed 5-6 ECs surrounding a single 
HSPC. Time-lapse live imaging of endogenous Runx+ HSPCs in the embryo using our 
novel transgene has revealed striking interactions with perivascular ECs in the niche 
microenvironment. 
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Figure 6. Remodeling of the perivascular niche after HSPC arrival in the CHT 
 
(A) 4 frames selected from time-lapse Movie S2 between 40-42 hpf (hours:minutes). Upper row is a merge 
of Runx:GFP+ HSPC (green, middle row) and kdrl:RFP EC (red, lower row). A group of surrounding EC 
(broken circle) remodel around a single HSPC soon after its arrival. (B) Higher magnification (60x) live 
image of a single Runx:GFP+ HSPC surrounded by kdrl:mCherry at 78 hpf (orthogonal views). CV: caudal 
vein. (C) 3D rendered projection of scanning confocal image from fixed 80 hpf embryo. (i) merge, (ii) 
kdrl:mCherry EC, (iii) Runx:GFP+ HSPC, (iv) DRAQ5 nuclei, (v) kdrl:mCherry projection with modeled 
green HSPC and 5 blue surrounding EC nuclei (arrowhead indicates HSPC in EC surround). All views: 
dorsal up, ventral down. Scale bars: 10 µm. See also Figure S3. 
 
 
 
High-resolution ultrastructure of the perivascular niche surrounding an HSPC 
 We sought to better reveal the cellular interactions between an HSPC and its 
perivascular niche that would not otherwise be visible with confocal light microscopy. To 
do this we used correlative light and electron microscopy92.  First, to confirm that an 
HSPC was lodged in the CHT, we performed time-lapse live imaging of 
Runx:GFP;kdrl:mCherry embryos as above (Figure 6A). Imaging multiple stage-matched 
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embryos in parallel, we confirmed that 1-2 HSPCs per embryo had not only migrated to 
the CHT, but had also lodged and triggered an EC remodeling event that was stable for 
more than 6 hours (Figure 7A-B). Embryos were then fixed and embedded for electron 
microscopy (EM). Serial block face scanning EM captured large sections of the CHT at 
high resolution (Figure 7C; XY: 10 nm/pixel, Z: 100 nm/slice). Based on a number of 
cellular and anatomical markers (e.g. melanocytes, somites, vessels), the position of the 
lodged HSPC in time-lapse could be correlated with EM serial sections (Figure S4). 
 3D reconstruction of EM scans shows that the HSPC lodges in a region just below 
the ventral endothelial surface of the dorsal aorta. As predicted from our confocal 
microscopy analysis (Figure 6C), the HSPC is surrounded by at least 5 ECs. There are 
two stromal cells in proximity to the HSPC, but only one is in contact in a narrow region 
near the mid-point of the cell (Figure 7D). This is also consistent with our confocal 
microscopy of Runx+ HSPC and cxcl12a+ stromal transgenic lines (Figure 4G-I). An 
observation that could not have been made with confocal microscopy was that a fourth 
cell type (i.e. mesenchymal-like cells with melanophore inclusions), was found together 
with the HSPC, ECs, and stromal cells (Figure 7D,F and Movie S3). These two cells 
wrap the HSPC tightly and intertwine with each other. We found another example of an 
HSPC that is not associated with mesenchymal-like cells, or in proximity to stromal cells, 
but is surrounded by approximately 5 ECs, showing there are different configurations of 
this HSPC-EC niche (Figure S4). We were also able to identify Runx+ HSPC in time-
lapse movies that were transiently migrating through the CHT and had not lodged in the 
perivascular niche. These HSPC had only adhered to the vessel walls and in EM sections  
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Figure 7. Serial block face scanning EM of CHT after time-lapse 
 
(A) Last frame of CHT time-lapse (60 hpf). Arrowhead marks HSPC lodged >6 hours. Runx:GFP (green), 
kdrl:mCherry (red), brightfield (blue). Anterior left, posterior right, dorsal top, ventral bottom. 
 (B) Detail of region in (A) marked by box. (C) Single section and orthogonal slice from serial block face 
EM scans. Lodged HSPC is purple, surrounding EC nuclei are green and numbered, stromal cells are blue. 
(D) High resolution EM of HSPC lodged in perivascular niche just ventral to the dorsal aorta (circulating 
RBC visible). The HSPC (outlined in pink) is in direct contact with one stromal cell (light blue), is wrapped 
in 2 fibroblastic cells with melanophore inclusions (yellow and orange), and is surrounded by EC (3 of 6+ 
shown in green shades). (E,F) 3D rendered models of HSPC and niche in the same view as (D). 
Fibroblastic cells are not shown in (E) but are shown in (F). See also Figure S4 and Movie S3. 
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did not have the characteristic EC surround structure (data not shown). This further 
emphasized that the HSPC-EC niche formation event is rare and distinct. 
 
A chemical genetic screen to discover small molecule regulators of CHT niche 
colonization 
 Having tracked HSPC lodgement in the CHT niche, we wanted to identify the 
signaling mechanisms that regulate these cellular events. We performed a chemical 
genetic screen by introducing individual small molecules to embryos during the peak 
window of HSPC migration to the CHT (48-72 hpf; Figure 8). Hits were scored if they 
increased or decreased hematopoietic progenitor markers cmyb and runx1 with similar 
activities to control compounds (±)11,12-epoxyeicosatrienoic acid (EET; P.L. and L.I.Z., 
unpublished) or the CXCR4 antagonist, AMD3100, respectively. We chose AMD3100 as 
a positive control in the embryo because: 1) the duplicated homologs for CXCR4 and 
CXCL12 are expressed in the DA and CHT (cxcr4a/b and cxcl12a/b; Figure S5A); 2) the 
cxcl12a transgenic reporter93 is expressed in CHT stromal cells (Figure 4G-J); 6) 
AMD3100 blocks CXCL12-dependent migration of kidney marrow cells93.  After 
treating embryos with a range of AMD3100 doses, we observed dose-dependent 
reduction of HSPC markers in the CHT (Figures 8B,E and S5B). Following these results, 
we screened  ~2400 known bioactive compounds, and identified 40 individual 
compounds that increased and 107 that decreased CHT hematopoiesis. 
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Figure 8. Chemical genetic screen to identify small molecule regulators of CHT niche colonization 
 
(A-D) WISH of cmyb/runx1 probes in the CHT of 72 hpf embryos. Treatments from 48 hpf as indicated. 
(A) DMSO control with normal expression. (B) Low expression after 25 µM AMD3100 treatment. High 
expression after treatment with 40 µM SB-431542 (C) or 25 µM lycorine (D). (E) Percentage of total 
embryos scored with cmyb/runx1 expression levels as shown in (A-D). (F) Overview of chemical screen. 
(G) Selected frames from time-lapse movie of a Runx:GFP (green) x kdrl:RFP (red) double transgenic 
embryo treated with TGF-! inhibitor, SB-431542. In <90 minutes, an HSPC (a) undergoes rounds of 
division and releases daughter cells (b,c,e) into circulation (caudal artery, CA; circulation to posterior, 
right). (H) Lineage tree analysis of HSPC tracked in parallel time-lapse movies, with and without SB-
431542 treatment, from 44-60 hpf. One line is one continuously tracked HSPC from the time it enters the 
CHT field of view until it exits. Branch points mark cell divisions. The red box marks the lineage of the 
cells shown in (G). See also Figure S5. 
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Live imaging with small molecule regulators reveals distinct cellular behaviors within 
the CHT 
 We tested a subset of our chemical screen hits by adding individual compounds to 
the media of Runx:GFP+;kdrl:mCherry+ embryos during time-lapse imaging to directly 
observe the behavior of HSPC as they colonize the CHT. One of the hits in our screen 
that increased CHT hematopoiesis was SB-431542 (Figure 8C), a selective inhibitor of 
transforming growth factor (TGF)-! type I receptors, and most potently ALK5/TGFBR1.  
When added during time-lapse imaging, we observed normal HSPC arrival in the CHT 
and adherence to vessel walls. However, soon after arrival HSPCs began to undergo 
frequent rounds of asymmetric division (Figure 8G,H and Movie S4). One daughter cell 
would bud off into circulation, while the other remained adhered to the vessel wall. To 
quantify this difference, we performed lineage tree analysis of HSPCs during parallel 
time-lapse movies (i.e. control and treated stage-matched embryos imaged side-by-side; 
Figure 8H). Scoring cell divisions between 44 and 60 hpf, more HSPCs divided in SB-
431542 treated CHT movies (n=8-10 versus n=3-4 in DMSO treated controls). These 
data illustrate that inhibition of TGF-! receptor signaling using the chemical SB-431542 
expands HSPC populations by increasing the frequency of cell divisions. This is 
consistent with previously published in vitro and in vivo data that showed TGF-! 
signaling negatively regulates HSPC proliferation94–99.  Directly visualizing the effect of 
SB-431542 on HSPCs has demonstrated that we can rapidly identify cellular response to 
a specific signal in the endogenous niche. 
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 A second compound we identified in our screen was lycorine, a natural alkaloid 
extracted from the Amaryllidaceae plant family that dose-dependently increased cmyb 
and runx1 in the CHT (Figure 8D and 9A). This drug does not have a defined target or 
mechanism of action, but is a candidate anti-inflammatory and anti-cancer drug (Kang et 
al., 2012; Lamoral-Theys et al., 2010; Yamazaki and Kawano, 2011). Running parallel 
time-lapse movies, we observed more HSPCs nestled in the CHT in lycorine-treated 
embryos compared to controls (Figure 9B,C). Over time, lycorine treatment dramatically 
increased HSPC number in the CHT (Figure 9D). We also scored the total amount of 
time each HSPC was resident in the CHT during the time-lapse, and found lycorine 
treatment produced a significant shift towards longer durations spent in the niche (Figure 
9E; median difference 1.67 hours; Wilcoxon signed rank test, p=0.01). Lycorine 
treatment during the peak of CHT colonization also had a sustained effect on the total 
number of HSPC in the embryo. A pool of Runx:GFP+ embryos that were treated with 
lycorine from 2-3 dpf then washed off, had a significantly higher number of GFP+ 
HSPCs at 7 dpf compared to DMSO controls (Figure 9F). To obtain a better 
understanding of the molecular effects of lycorine on HSPC, we treated 
Runx:GFP;kdrl:RFP embryos from 2-3 dpf, then sorted Runx+ HSPCs and kdrl+ ECs for 
whole genome microarray analysis. (Figure S6).  Lycorine treatment induces significant 
changes in both HSPC and EC that promotes the interaction of HSPC with the 
perivascular CHT niche. 
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Figure 9. Lycorine modulates HSPC-EC interactions in the CHT 
 
(A) Lycorine treatment dose-dependently increases the percentage of embryos with high cmyb/runx1 
expression levels, as shown in Figure 5D. (B-C) Stage-matched frames at 42 hpf from parallel time-lapse 
movies of Runx:GFP;kdrl:RFP double transgenic embryos. There are more HSPCs (marked with 
arrowheads) in lycorine-treated (25 µM) embryos (C) compared to DMSO-treated controls (B). (D) HSPCs 
are counted in each frame of a time-lapse movie and then averaged each hour. 5 movies imaged in parallel: 
n=2 controls and n=3 lycorine-treated (25 µM). (E) Same movies as in (D) were scored for continuous 
hours an HSPC was tracked in the CHT. There was a significant difference in the median time HSPC spent 
in the CHT between controls and lycorine-treated embryos (1.67 hours; Wilcoxon signed-rank test, p=0.01; 
HSPC counts were normalized because the lycorine group had 3 embryos and the control group had only 
2). (F) Pools of Runx:GFP+ embryos treated with lycorine from 2-3 dpf have significantly increased HSPC 
at 7 dpf (p=0.0004; FACS of 4 independent pools per dose). Error bars show mean ± s.e.m. See also Table 
S1. 
 
 
Endothelial niche remodeling is conserved in mammalian fetal liver 
 It was important to establish if the distinct endothelial niche structure we 
identified in the zebrafish CHT was also found in mammals. The equivalent tissue is the 
FL as it is the first tissue colonized by definitive HSPC from the dorsal aorta. The FL is 
an intermediate site of hematopoiesis where HSPC expand before leaving to colonize the 
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adult marrow and it produces the majority of blood during development90,100,101. To 
examine the earliest stages of FL colonization, we dissected E11.5 FL from Ly6a-GFP 
(Sca-1) mice, which have GFP+ HSPC102,103.  Together with HSPC marker Runx1, and 
EC marker VE-cadherin (Cdh5), we found Ly6a-GFP+/Runx1+ HSPC in one of 3 
compartments in the FL: 1) an abluminal space with no EC contact (Figure 10A); 2) 
adherent to EC on one side (Figure 10B); 3) inside an EC pocket (Figure 10C and Movie 
S5). The similarity of a single HSPC surrounded by a small group of EC in both the 
mouse FL and zebrafish CHT (compare Figure 6B and 10C), suggests that this cellular 
structure is important for stem cell lodgement in hematopoietic niches. 
 The identification of a potentially conserved HSPC-endothelial niche structure 
raised the possibility that HSPC also trigger a dynamic remodeling of EC during 
colonization of the FL. The FL tissue in mouse is not directly accessible to confocal 
microscopy, so we instead applied a protocol for live imaging of embryo explants.  We 
dissected wild-type and Ly6a-GFP E11.5 FL, soaked the explant FL in fluorescently 
conjugated antibodies to detect c-kit+ HSPC and CD31+ (Pecam1+) EC, and 
immediately performed live imaging for up to 4 hours. We observed c-kit+ hematopoietic 
cells adhered to the sinusoidal network of CD31+ EC (Figure 10D-E and S7). We 
followed a c-kit+ HSPC attached to the sinusoid as it migrated into a small group of EC 
(Figure 10D and Movie S6). Next, EC tightly surrounded the HSPC in what looked 
strikingly similar to endothelial niche remodeling in the zebrafish CHT (compare Figure 
6A and 10D). Tracking a Ly6a-GFP+/c-kit+ HSPC in another explant, we observed one 
cell division (Figure 10E). Intriguingly, the daughter cell proximal to the sinusoid 
remained surrounded by EC, while the daughter cell distal to the sinusoid migrated away  
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Figure 10. Conserved remodeling of ECs around HSPCs in the mouse fetal liver 
 
(A-C) Fetal livers from E11.5 Ly6a-GFP mice were fixed and stained for immunofluorescence with anti-
VE-Cadherin (red), anti-Runx (blue), and anti-GFP (green) antibodies. We scored 59 Ly6a-GFP+/Runx1+ 
cells from 3 fetal livers and identified three different HSPC-EC configurations: (A) abluminal with no 
contact between HSPC and EC; (B) EC contact on one side of the HSPC; (C) HSPC surrounded on all sides 
with EC. See Movie S5. (D) An HSPC with c-kit+ accumulation (magenta) is shown adhered to CD31+ 
endothelial sinusoid (green) in one lobe of an E11.5 FL (arrowhead). The white box marks details below. 
Key time-lapse frames show in <90 minutes the HSPC migrates into a field of SEC. Soon after the SEC 
surround the HSPC to form a niche. See Movie S6. (E) Ly6a-GFP+ HSPC (green) is adhered to the 
abluminal side of a CD31+ sinusoid (red), with a c-kit+ contact point (blue). Following this same cell for 
>2 hours (1 frame/5 minutes), shows the cell divides, with one cell remaining in the endothelial niche and 
the other migrating away. See Movie S7. Confocal images are 3D rendered depth projections (A,B,C,E), 
orthogonal views (A,B,C below) or maximum projections (A) of z-stacks. Scale bars: 10 µm. See also 
Figure S6. 
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into the abluminal space (Figure 10E and Movie S7). In another time-lapse sequence, a c-
kit+ HSPC was observed undergoing discrete steps towards lodgement: adherence, 
extravasation, abluminal migration, and endothelial niche remodeling (Figure S7A-C). 
We also identified an accumulation of c-kit at the contact point between the HSPC and 
EC (Figure 10E and S7C).  This observation is similar to data that showed c-kit 
condenses with clustering lipid rafts in cytokine-induced HSPC104,105.  Even with the 
caveat that FL explants have been removed from circulation and are imaged ex vivo, our 
live imaging data strongly suggest an evolutionary conserved process of dynamic EC 
remodeling around a single HSPC in a hematopoietic niche. 
 
Discussion 
 The ability to follow endogenous HSPCs in the live zebrafish as they lodge in a 
niche has allowed us to capture never before seen cellular behaviors during this important 
event in the life of a stem cell. This high-resolution view of the zebrafish CHT has shown 
events that have not been visible in the mammalian bone marrow. We watched as HSPCs 
attached to the endothelial wall of a vessel, underwent extravasation, migrated into the 
abluminal space, then triggered a striking endothelial remodeling event to form a niche 
(summarized in Figure S3D). Live imaging of mouse FL explants revealed that these 
steps towards HSPC lodgement are highly conserved. This high resolution tracking of 
HSPC interaction with the perivascular niche opens many possibilities to further dissect 
the mechanisms of hematopoietic colonization. 
 The combination of time-lapse live imaging and chemical genetics in the 
zebrafish has enabled us to rapidly screen compounds that have an effect on endogenous 
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HSPCs in their microenvironment. We have validated this approach by showing that 
signaling pathways with well-established roles in HSPC trafficking and proliferation, 
CXCR4-CXCL12 and TGF-!, respectively also regulate HSPCs in the zebrafish embryo. 
We found that treatment of the embryo during CHT colonization with the compound 
lycorine dose-dependently increased the number of hematopoietic progenitors. Analysis 
of live imaging data suggested that HSPCs accumulated in the CHT because of longer 
interaction times with the perivascular niche. The additional finding that the increase in 
HSPC number was sustained long after lycorine was removed raises the possibility that 
HSPC-niche interactions during development could have a role in determining the long-
term size of the stem cell pool. We are currently testing this hypothesis at later time-
points and into adulthood. To reveal clues to the mechanism of lycorine action, we 
isolated HSPC and EC from lycorine-treated embryos. We found there was cell type-
specific variations in gene expression that point to changes in the migratory and adhesive 
properties of HSPC and EC. Our results show there is a functional role for interactions 
between HSPC and EC during development, and this may be important for setting aside 
the long-term hematopoietic stem cells that will colonize the adult marrow. 
 Our finding that HSPC arrival triggers cellular changes in the local perivascular 
niche raises interesting questions about what constitutes a hematopoietic stem cell niche. 
Rather than a static number of niches that can be either cleared or filled (Schofield, 
1978), our results are suggestive of basic niche components that create a permissive 
environment for an arriving stem cell. Once attracted to these general locations in the 
marrow, the stem cell will move out of circulation and lodge in its new surroundings. The 
rapid remodeling of endothelial cells around a stem cell may provide a mechanism to 
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retain and protect these new arrivals. It will be important to determine how much 
plasticity there is in the number and locations that a stem cell can reside. We focused our 
study on the hematopoietic microenvironment in the zebrafish CHT and mouse fetal 
liver. These are intermediate niches are required to rapidly expand the stem cell pool. 
With continual advancements in imaging technology we will soon be able to resolve 
similar cellular dynamics in the adult marrow. 
 Prior to HSPC transplantation, myelosuppression by chemotherapy or irradiation 
is used to condition a recipient and prepare their bone marrow to receive donor stem 
cells. Conceptually, this has been thought to “clear” or “open” the niche. However, 
studies have shown that myelosuppression causes significant damage to the bone marrow 
vascular epithelium that must be repaired for hematopoiesis to recover (Hooper et al., 
2009). This has presented a dynamic model of the vascular niche that requires 
angiogenesis, together with engraftment of incoming HSPC, to rebuild a functional 
hematopoietic bone marrow. The ability to modulate these HSPC-EC interactions, as we 
and others have started to demonstrate, will likely have an important impact on clinical 
stem cell transplantation. 
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Addendum 
 
 
 A chemical screen for CHT colonization in zebrafish embryos demonstrated that 
signaling pathways with well-established roles in HSPC trafficking and proliferation also 
regulate HSPCs in zebrafish.  AMD3100, a CXCR4 antagonist, dose-dependently 
decreased the numbers of HSPCs that localized to the CHT during embryogenesis.  In 
addition, we identified a number of small molecules that regulate the sphingosine-1-
phosphate (S1P) pathway, which has previously been shown to play a role in chemotaxis 
and cell migration.  Out of the 5 G-protein coupled receptors for S1P, S1PR1 is 
considered to be the one that is critical for blood cell migration.  We looked at the 
expression pattern of S1PR1 receptor during the key stages of CHT colonization and 
found that it’s expressed in both the dorsal aorta and the CHT.   
 To test if there was an interaction between CXCR4 and S1PR1 signaling, two 
important pathways that reduce CHT hematopoiesis, we used a chemical genetic 
interaction matrix, taking advantage of two clinically relevant small molecule regulators 
of these receptors: AMD3100 and FTY720 (Figure 11).  This matrix demonstrated that 
there were combined doses of the two drugs that increased CHT hematopoiesis at 
concentrations where one drug alone had no effect.  This result is highly suggestive of an 
interaction between these pathways in colonization of the CHT.   
 This result suggested a potential for modulating both homing and engraftment in 
mammals.  SDF-1, the ligand for CXCR4, and S1P, the ligand for S1PR1, are both 
powerful chemoattractants for murine HSCs, which express both receptor types.  
However, whereas SDF-1 levels are high in the bone marrow and cause HSCs to home to 
the niche via CXCR4, S1P levels are quite low in tissues, and are most highly expressed  
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Figure 11:  Chemical interaction matrix of FTY720 and AMD3100 
 
Zebrafish embryos were treated from 48hpf-72hpf with the doses of chemical indicated on the matrix.  In 
situ hybridization was performed for runx1/cmyb+ cells.  “0” score indicates no change in cell number from 
control, +2 indicates an increase of runx1/cmyb+ in the CHT, -2 indicates a decrease. 
 
 
 
in the blood.  The S1P agonist SEW2781 enhances HSC mobilization from the bone 
marrow following CXCR4 inhibition by AMD3100.  This suggests an intricate 
connection between the CXCR4/SDF-1 and S1PR1/S1P signaling pathways to control 
HSC migration in and out of the bone marrow.  Based on our chemical matrix and 
previous data, we hypothesized that during niche colonization HSCs respond and migrate 
towards high levels of S1P in the blood.  Once in circulation, HSCs internalize S1PR1 
and CXCR4 emerges on the surface of these cells.  This allows HSCs to home to the 
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CHT, where CXCR4 internalizes and S1PR1 resurfaces once again, to enable cells to 
migrate to the next site. 
 To examine the effect of these two drugs on CXCR4 and S1PR1 expression in 
mice, we treated whole bone marrow cells with varying doses of AMD3100 and FTY750 
and performed FACS analysis to look at surface receptor expression.  We found that 
treatment with either of the drugs alone, or in combination, resulted in dynamic changes 
in receptor expression (Figure 12).  Treatment with higher doses of AMD3100 alone 
decreased CXCR4 expression while S1PR1 expression was increased.  Conversely, 
treatment with FTY750 alone increased S1PR1 and decreased CXCR4 expression.  
Interestingly, combination treatments showed both increases and decreases in receptor 
expression dependent on dose.  
  
 
 
 
Figure 12: S1PR1 and CXCR4 receptor expression data in WBM cells  
 
WBM was treated for 60 min at 37oC (n=8 total from 2 experiments), cells were sorted for lineage negative 
population and analyzed by FACS for receptor expression. The graph shows the change in number of 
WBM cells expressing receptor (log2, relative to control).  
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  We next wanted to check if these changes in receptor expression level were 
correlated with changes in HSC homing and mobilization.  We performed homing 
transplants using 4 X106 CD45.1 WBM cells treated with PBS, FTY750 alone, AMD 
3100 alone, or a combination, for 1 hour.  Cells were mixed with equal numbers of 
CD45.1.2 WBM cells and injected into CD45.2 recipient mice.  16 hours following 
transplantation, the marrow of recipient mice was harvested and stained for CD45 
markers.  As expected, we found a slight decrease in the homing capabilities of cells 
treated with AMD3100 alone (Figure 13).  Interestingly, we found that the combination 
treatment resulted in a slight increase of homing potential, however these results must be 
repeated with optimized conditions.  
 
  
Figure 13:  Effect of AMD3100 and FTY720 treatment on homing of WBM cells 
 
WBM cells were treated with AMD3100, FTY720, or both for 1 hour.  The graph indicates the ratio of 
treated cells: competitor cells in the marrow of recipient mice.  These results were obtained 16 hours post 
transplantation.  N=5 mice/group. 
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We also wanted to observe the combinatorial effects of these drugs on the mobilization of 
HSCs from the bone marrow to peripheral blood.  In vivo treatment of mice with 
AMD3100 results in a dramatic increase of HSCs in circulation that peaks at 1-hour post 
injection and steadily decreases thereafter.  We injected mice with PBS, AMD3100 
alone, or AMD3100+FTY750 at multiple doses.  At 1-hour post injection, we bled the 
treated mice and performed colony-forming assays to confirm the presence of HSCs in 
the peripheral blood.  As expected, mice treated with PBS had essentially no circulating 
HSCs, evidenced by the absence of colonies at day 7, whereas mice treated with 
AMD3100 alone had high levels of circulating HSCs (Figure 14).  The addition of 
FTY750 did not enhance mobilization over AMD3100 alone.  However a low dose of 
FTY750 (0.01mg/kg) resulted in significantly more colonies than a high dose (1.0mg/kg).  
 
  
Figure 14:  Effect of AMD3100 and FTY720 treatment on mobilization of HSCs 
  
Graph shows the number of colonies on day 7 from peripheral blood that was isolated from mice 1 hour-
post treatment with various drugs (as indicated in figure legend). 
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 Our results suggest that we can modulate the processes of homing and 
mobilization using small molecule regulators of migration pathways and are consistent 
with recently published studies106,107.  Further characterization of the CXCR4 and S1PR1 
receptor dynamics in response to chemical modulation will be necessary to take 
advantage of this interaction.  In the future, it should be possible to identify combinatorial 
doses of AMD3100 and FTY750 that favor either mobilization or homing.  These 
treatment regimens could have useful clinical applications. 
 !!!!!!!!!!!!!!!!
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Chapter 3 
 
 
Prostaglandin E2 regulates long-term repopulation activity of ST-HSCs 
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Abstract 
 16,16- dimethyl prostaglandinE2 (dmPGE2) increases the number of embryonic 
HSCs in zebrafish and improves long-term engraftment of bone marrow and cord blood 
transplantation. The mechanism of signaling has been shown to involve CXCR4 
upregulation and wnt activation, but the cellular activity of dmPGE2 remains to be 
determined. To investigate the long-term effects of dmPGE2, we transiently treated 
zebrafish embryos from gastrulation to 36 hours post fertilization (hpf), and grew up 
these animals to 3-4 months of age. Kidney marrow (KM) cells from adult zebrafish 
pulse-treated with dmPGE2 during embryogenesis were studied in a competitive 
transplantation experiment using GFP+ treated KM and untreated DsRed KM. The ratio 
of GFP+ cells present in KM 3 months post-transplant was higher in dmPGE2-treated 
groups compared to control (1.25 vs. 0.68, p<.001). We tested the ability of dmPGE2 to 
confer a long-term advantage on sorted marrow populations in competitive 
transplantation assays in the mouse. ST-HSCs, but not LT-HSCs or MPPs, showed 
enhanced reconstitution in recipient animals a full 12 months after dmPGE2 exposure, 
compared to control animals.  The effects of dmPGE2 on HSC function persist over 
substantial time despite transient exposure, and suggest the long-term effects of dmPGE2 
are due to a stimulatory effect on the ST-HSC population to acquire long-term activity.  
Gene expression data and ChIP-seq analysis in human CD34+ cells suggests that dmPGE2 
may play a role in the quiescent state of these cells.  Our studies are the first to 
demonstrate that a small molecule can prevent exhaustion of ST-HSCs, which facilitates 
long-term reconstitution following transplant. 
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Introduction 
 Hematopoietic stem cell transplantation (HSCT) is an effective treatment for 
blood disorders and autoimmune diseases. Enhancing hematopoietic stem and progenitor 
cell (HSPC) frequency and function will shorten engraftment time and lower risk factors 
in myeloablated patients. 16,16- dimethyl prostaglandinE2 (dmPGE2) was previously 
identified in a chemical screen and found to regulate HSC development during zebrafish 
embryogenesis43.  The effect of dmPGE2 on hematopoiesis is conserved in mammals.  
Several groups have demonstrated that ex vivo treatment of dmPGE2 confers an 
advantage on mouse marrow cells in competitive repopulation studies43,46.  Treatment of 
human CD34+ cells with dmPGE2 prior to transplantation into immunodeficient mice 
results in increased chimerism in the peripheral blood and bone marrow of recipients48. 
Long-term transplantation studies have been carried out to analyze the repopulation 
kinetics of marrow cells following pulse exposure to dmPGE2.   Recipient mice have 
normal blood counts and bone marrow histology through quinary transplants, with an 
absence of lineage bias; demonstrating that pulse treatment of dmPGE2 does not lead to a 
cancerous phenotype108.  In addition, bone marrow cells pre-treated with dmPGE2 are 
protected from hematopoietic injury when exposed to chemotherapy reagents.  Treated 
mice display accelerated recovery of hematopoiesis following total body irradiation109.  
These data suggest ex vivo treatment with dmPGE2 as a potential clinical therapy to 
enhance HSPC engraftment following transplantation.  
 A recent phase 1 trial assessed the potential of dmPGE2 treatment to increase the 
effective dose of HSCs for umbilical cord blood (UCB) transplantation49.  Although 
transplanting cord blood reduces the stringency for HLA matching, the concentration of 
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HSPCs per cord blood unit (CBU) is too low for successful engraftment in adult 
recipients.  The current standard for UCB transplantation is to infuse a patient with 2 
CBU.  To determine whether dmPGE2 treatment improves engraftment of cells following 
UCB transplantation, patients were infused with one dmPGE2-treated CBU and one 
untreated CBU.  Ex vivo pulse with dmPGE2 enhances the engraftment of CBU in 
patients as determined by the median time to neutrophil engraftment (17.5 days vs. 21 
days).  Chimerism analysis demonstrated that the dmPGE2-treated cord preferentially 
engrafted in >80% of patients.  Historically, there is a 50% chance for either cord unit to 
reconstitute a patients’ hematopoietic system.  These preliminary results have exciting 
therapeutic implications.  It may be possible to eliminate the need for a second CBU, 
which would reduce strain on current resources.  Shortening engraftment time will also 
reduce the risk of infection to myeloablated patients. 
 Although UCB has emerged as a valuable source of HSPCs for transplantation, 
there are limitations for its use in adult patients.  Recently, studies have aimed to 
chemically manipulate these cells ex vivo with the goal of expanding HSPCs prior to 
transplant, or to enhance homing and engraftment of these cells following transplantation.  
Improving either of these aspects would allow more patients to benefit from the 
advantages of cord blood transplantation.  Using small molecules to treat entire CBUs 
can be somewhat complex; cord blood cells are a heterogeneous population that contains 
not only HSPCs but also mesenchymal stem cells, endothelial progenitors, and naïve 
immune cells110.  In addition to its effects on HSPCs, dmPGE2 has immunomodulatory 
effects and promotes the survival of naïve UCB T cells through the Wnt/!-catenin 
pathway111.  This protective effect could enhance recipient T-cell chimerism following 
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transplant.  This has important clinical implications since delayed immunological 
reconstitution is a huge risk factor for transplant patients.    
 The initial chemical screen in zebrafish that identified PGE2 as a regulator of 
HSPCs showed an increase in runx1 and cmyb positive cells, a heterogeneous population 
that includes HSCs, progenitors, and differentiated myeloid cells43.  Follow-up studies in 
mice demonstrated that dmPGE2 enhances the homing and transplantation of murine LSK 
cells and human CD34+ cells, both heterogeneous populations46,48.  Serial transplants in 
mice suggest that PGE2 is acting on a long-term repopulating cell, yet treated LT-HSCs 
do not demonstrate enhanced repopulation compared to control cells108.  Consistent with 
these results, mice treated in vivo with dmPGE2 show no change in LT-HSC frequency, 
but display an increase of ST-HSCs/MPPs.  These results suggest that a population of 
cells distinct from LT-HSCs mediate the effects of PGE2. 
 ST-HSCs/MPPs are functionally defined by their multipotent but transient 
repopulation capacity27.  Transplantation of ST-HSCs/MPPs from mice that are 
continuously treated with dmPGE2 into irradiated recipients results in enhanced short-
term, but not long-term reconstitution, most likely due to exhaustion.  In contrast, we 
have found that ST-HSCs treated with an ex vivo pulse of dmPGE2 enhance long-term 
reconstitution for up to 1-year post transplant compared to control cells.  Treated ST-
HSCs maintain improved function in secondary transplants without additional exposure 
to dmPGE2.  We have found through microarray and ChIP-seq analysis in human CD34+ 
cells that dmPGE2 induces gene expression that is associated with quiescence.  
Stimulation of this gene signature may prevent exhaustion of ST-HSCs.  Our results show 
that dmPGE2 enhances the long-term potency of ST-HSCs, which were previously 
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thought to have transient reconstitution capabilities.  Identifying the subpopulation of 
HSPCs that is responsive to dmPGE2 has important therapeutic implications and may 
help to improve pre-transplantation expansion protocols.     
       
       
 
Materials and Methods 
Zebrafish maintenance and lines 
 Zebrafish and mice were maintained in accordance with Animal Research 
Guidelines at Children's Hospital Boston.  Embryo chemical treatments were performed 
in 1XE3 fish water.  
 
HSPC population FACS sorting 
 HSPC populations were sorted from freshly isolated WBM cells using a FACS 
ARIA (BD Biosystems) using the following antibodies: Lineage- Ter119, CD4, CD8, 
B220, Mac1, Gr-1 (PE-cy5) Sca1 (PE) cKit (APC) CD48 (Pacific Blue) CD34 (FITC) 
CD150 (PE-cy7).  The following marker combinations were used to differentiate LT-
HSCs (LSKCD48-CD34-CD150+), ST-HSCs (LSKCD48-CD34+CD150+), and MPPs 
(LSKCD48-CD34+CD150-) 
 
Adult zebrafish repopulation assays 
 WKM cells from 3-month donor fish were isolated and sorted by FACS (Runx1+ 
cell transplants) or counted using a hemocytometer (WKM transplants).  Donor cells 
were transplanted into irradiated casper recipients  (30gy, split dose) along with untreated 
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helper marrow.  Transplantation procedures were performed as previously described82.  
At 3 months post-transplant, WKM from recipient fish was collected and analyzed by 
FACS to detect chimerism levels of mCherry and GFP-positive cells in the marrow or by 
fluorescence microscopy.   
 
WBM repopulation assays 
 Recipient mice (C57bl/6 CD45.2) are irradiated with 8Gy the day before 
transplantation.  Bone marrow cells are freshly isolated from donor mice (SJL CD45.1).  
Spin down harvested marrow cells and resuspend cells in DMEM +2%FBS for treatment.  
Marrow cells are treated with 10uM dmPGE2 or DMSO for 2 hours on ice.  Treated cells 
are competed against freshly isolated CD45.2 cells.  For sorted transplants, HSPC 
populations are FACS-sorted as described above.  Individual populations are then treated 
with 10uM dmPGE2 or DMSO for 2 hours on ice and transplanted along with helper 
marrow (200K or 400K).  For 5-FU transplants, donor mice were treated with 5 FU or 
PBS as previously described112.  Marrow was harvested two days later and treated with 
10uM dmPGE2 or DMSO for 2 hours on ice and transplanted along with 200K helper 
marrow cells.  
 
PB chimerism analysis 
 Peripheral blood was isolated from recipient mice by RO bleed every 4 weeks 
following transplantation.  Red blood cells were lysed and white blood cells were 
analyzed using the following antibody combinations for multilineage engraftment: 
Ter119 (PE-cy5) Mac1 (Alexa680) Gr-1 (PE-cy7) B220 (Pacific blue) CD3 (APC) 
CD45.1(PE) and CD45.2 (FITC). 
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pCREB ChIP-sequence 
 Human CD34+ isolated cord blood cells were treated with 10uM dmPGE2 or 
DMSO for 2 hours at 37oC.  ChIP was performed with a pCREB antibody from Santa 
Cruz (sc-7978) as previously described113.   
  
 
 
 
   
Results 
PGE2 increases runx1+ HSPCs in embryo and adult zebrafish 
 
 Treatment with dmPGE2 was previously shown to increase the number of 
runx1/cmyb+ cells in zebrafish embryos by in situ hybridization.  We tested the effect of 
dmPGE2 on a runx1:GFP transgenic line that labels HSPCs.  Embryos were treated from 
3 somite stage (ss) to 36 hpf with 50µM dmPGE2 or DMSO as control.  The chemical 
was washed off at 36 hpf and embryos were imaged using confocal microscopy at 60 hpf.  
Consistent with previous results, we observed an increase of runx1+ GFP cells in the 
caudal hematopoietic tissue (CHT) of dmPGE2-treated embryos compared to controls 
(Figure 15).  Given that the increase of runx1+ cells was still present a full day after 
dmPGE2 was removed, we next looked at these cells in the whole kidney marrow (WKM) 
of adult fish.  Runx1:GFP fish were treated with dmPGE2 or DMSO from 3ss-36hpf, at 
which point chemical was removed and embryos were grown to adulthood.  FACS 
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analysis of WKM at 3 months revealed the number of runx1+ HSPCs was increased in 
fish previously treated with dmPGE2 (Figure 16).  This indicates that the enhancement of 
HSPCs by dmPGE2 during embryogenesis is maintained through development to 
adulthood.    
         
        
 
 
 
 
 
 
 
 
 
 
Figure 15: dmPGE2 increases Runx1+ cells in the CHT 
Zebrafish embryos were treated from 3ss-36hpf with 50uM dmPGE2 (bottom panel) or DMSO (top panel).  
The cartoon image demonstrates the region of the CHT depicted in the confocal image at 60hpf.  HSPCs 
are labeled with GFP, endothelial cells are labeled with dsRed. 
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Figure 16: dmPGE2 increases Runx1+ cells in the adult kidney marrow 
Zebrafish embryos were treated from 3ss-36hpf with 50uM dmPGE2 or DMSO and then chemical was 
removed. Fish were grown up to adulthood and kidney marrow was dissected and FACS-analyzed for 
Runx1+:GFP cells. 
 
 
 
Short-term exposure of PGE2 enhances long-term repopulation of the HSPC pool 
 Our initial data from zebrafish and previous work by others in the murine system 
demonstrated that a short pulse of dmPGE2 leads to long-term effects on HSPCs43,46,108.  
We confirmed this in the mouse using competitive transplantation assays.  Primary 
competitive transplants were performed using freshly isolated CD45.1 cells treated with 
dmPGE2 or DMSO.  Treated cells were competed against fresh CD45.2 competitor 
marrow.  FACS analysis on peripheral blood (PB) demonstrated robust chimerism in 
mice that received dmPGE2-treated cells compared to mice receiving cells treated with 
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DMSO.  Recipients in the dmPGE2 group at 1-year post transplant maintain increased PB 
chimerism without lineage skewing (Figure 17).  To test the robustness of treatment with 
dmPGE2 on repopulation capability, we performed competitive secondary transplants. 
WBM from primary recipient mice in each group was harvested at 1-year post transplant 
and FACS-sorted to isolate CD45.1 positive cells.  These cells were transplanted in the 
presence of fresh CD45.2 competitor cells without additional dmPGE2 or DMSO 
treatment.  PB chimerism analysis at 24 weeks post transplant indicates that dmPGE2-
treated cells were still able to out-compete control cells in secondary transplantation 
assays without disrupting differentiation status (Figure 18).  
 Collectively, our results demonstrate that just a brief (2-hour) ex vivo exposure of 
WBM cells to dmPGE2 confers long-term repopulation advantage that is maintained 
through multiple rounds of transplantation.  We next wanted to examine if dmPGE2 
treatment months prior to transplantation would enhance the repopulation capacity of 
HSPCs.  Since this type of experiment would be technically challenging in mice, we 
utilized the zebrafish to treat embryos during HSPC specification.  We tested the ability 
of pulse treatment with dmPGE2 during zebrafish embryogenesis to confer a 
transplantation advantage on adult WKM cells.  !-actin:GFP embryos were treated with 
dmPGE2 or DMSO.  Following this treatment, the chemical was washed off and fish were 
left to grow to adulthood.  After 3 months, WKM was harvested and prepared for 
transplantation into irradiated recipient fish.  20,000 WKM cells from each treated fish 
were competitively transplanted against 80,000 cells from untreated RedGlo fish into 
casper recipients (Figure 19a).   
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Figure 17:  dmPGE2 increases long-term repopulation in primary recipients 
 
Analysis of PB chimerism was performed 1-year post transplantation in mice that received DMSO-treated 
cells (filled circles) or dmPGE2-treated cells (open circles).  Multilineage reconstitution was determined by 
assessing B cells, myeloid cells, and T cells.  Each circle represents an individual recipient.  
 
   
 
Figure 18:  dmPGE2 increases long-term repopulation in secondary recipients 
 
Analysis of PB chimerism was performed 20 weeks post secondary transplantation in mice that received 
DMSO-treated cells (filled circles) or dmPGE2-treated cells (open circles).  Multilineage reconstitution was 
determined by assessing B cells, myeloid cells, and T cells.  Each circle represents an individual recipient.  
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Figure 19a:  Schematic of adult WKM transplant  
 
Zebrafish embryos were treated with DMSO or dmPGE2 from 3ss-36hpf.  Chemical was removed and fish 
were grown to adulthood.  Marrow from treated fish was transplanted into casper recipients. 
 
   
Figure 19b:  dmPGE2 treatment during embryogenesis enhances adult transplantation  
 
Each column represents recipients that received marrow from a single donor fish previously treated with 
DMSO (filled circles) or dmPGE2 (open circles).  Each dot represents an individual recipient fish.  The Y 
axis represents the ratio of green (treated) cells versus red (competitor) cells in recipient kidney marrow. 
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Four months following transplantation, recipient fish were imaged using a fluorescent 
microscope and the ratio of green to red cells (treated: untreated) in each kidney analyzed 
using ImageJ software.  We observed that transient treatment with dmPGE2 during 
embryogenesis resulted in increased transplantation potential in adults (Figure 19b).  We 
next tested this transplantation assay using runx1:GFP fish to examine at the effect of 
dmPGE2 on HSPCs specifically.  Interestingly, when equal numbers of runx1+ cells were 
competitively transplanted into recipient fish, the advantage of dmPGE2 treatment was 
lost.  This suggests that in vivo treatment of zebrafish with dmPGE2 results in a long-term 
repopulation advantage due to an increase in the runx1+ pool, rather than a change in 
inherent cell competitiveness.  These results are consistent with murine transplantation 
experiments in which equal numbers of LSK SLAM cells from primary recipients mice 
did not demonstrate an advantage of dmPGE2 treatment in secondary transplants.  
 
PGE2 preferentially affects ST-HSCs 
 Previous transplantation studies using dmPGE2 have been performed on fairly 
heterogeneous cells populations, including runx1+ cells in zebrafish, WBM or LSK cells 
in mice, and CD34+ human cells. To differentiate the effects of dmPGE2 treatment on the 
repopulation potential of individual stem and progenitor cell populations, we performed 
competitive transplants using sorted mouse marrow.   WBM was FACS-sorted into three 
populations that we will refer to as MPPs (LSKCD150-CD34+), ST-HSCs 
(LSKCD150+CD34+), and LT-HSCs (LSKCD150+CD34-).  Cells were treated with 
dmPGE2 or DMSO and transplanted in various doses against competitor cells (outlined in 
Figure 20).  Interestingly, sorted LT-HSCs or MPPs treated with dmPGE2 lost their 
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competitive advantage in transplantation assays.  However, ST HSCs treated with 
dmPGE2 displayed increased PB chimerism in recipients that was stable 1-year post 
transplantation (Figure 21).  In addition, when we further purify this population by 
selecting against CD48, the effect of dmPGE2 on repopulation is enhanced (Figure 22).  
Together, these data suggest that the long-term transplantation effects of dmPGE2 are 
mediated through the ST-HSC compartment. 
 
    
Figure 20:  Schematic of HSPC-sorted population transplants  
 
Whole bone marrow is harvested from donor mice and stained with FACS antibodies.  Cells are sorted into 
LT-HSCs, ST-HSCs, or MPPs.  Cells are treated ex vivo with DMSO or dmPGE2 before transplantation 
along with competitor marrow. 
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Figure 21:  dmPGE2 treatment enhances long-term repopulation of ST-HSCs  
 
LSK cells were further purified for ST-HSCs using CD150 and CD34 (red box). Analysis of PB chimerism 
was performed at 4 weeks (left graph) and 24 weeks (right graph) post transplantation in mice that received 
DMSO-treated ST-HSCs (filled circles) or dmPGE2-treated ST-HSCs (open circles).  Multilineage 
reconstitution was determined by assessing B cells, myeloid cells, and T cells.  Each circle represents an 
individual recipient.  
   
   
Figure 22:  The effect of dmPGE2 is enhanced in a subset of ST-HSCs  
 
ST-HSCs were further purified by negative selection of CD48 (LSKCD48-CD34+CD150+).  Analysis of PB 
chimerism was performed at 24 weeks post transplantation in mice that received DMSO-treated ST-HSCs 
(filled circles) or dmPGE2-treated ST-HSCs (open circles).  Multilineage reconstitution was determined by 
assessing B cells, myeloid cells, and T cells.  Each circle represents an individual recipient.  
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PGE2 may protect cycling cells from exhausting 
 ST-HSCs are functionally distinguished from LT-HSCs by their transient ability 
to repopulate all lineages of the blood.  This behavior reflects a key distinction in cycling 
status between LT-HSCs and ST-HSCs; it is thought that quiescence prevents depletion 
of LT-HSCs, thereby preserving long-term repopulation activity.  dmPGE2 treatment has 
been shown to increase the percentage of cycling cells in vitro in all HSC populations, 
but the use of varying culture conditions and reporters of cell cycle status could be 
confounding factors.  It is unclear how PGE2 affects cell cycle kinetics in vivo, or whether 
it preferentially acts on cells that are proliferating or quiescent.  Given that dmPGE2-
treated ST-HSCs rapidly proliferate and give rise to long-term multilineage reconstitution 
in competitive repopulation assays, we wondered if PGE2 protects these cells from 
exhaustion.  To test the effect of dmPGE2 on cycling cells, we performed transplants 
using mice treated with 5-fluorouracil (5-FU) as donors.  Donor mice were injected with 
PBS or 5-FU such that HSCs will be forced into cycle112.  WBM cells were harvested and 
treated with DMSO or dmPGE2 before being transplanted with competitor marrow into 
recipients (Figure 23).  Consistent with previous results, mice that received cells from 5-
FU-treated donors displayed decreased chimerism compared to PBS controls at 4 weeks 
post transplant114 (Figure 24).  Cells treated with dmPGE2 performed better in both 
experimental groups.  Interestingly, by 12 weeks post transplant, recipient mice in the 5-
FU/dmPGE2 group had chimerism levels greater than PBS controls (Figure 24).  These 
data suggest that cycling HSCs treated with dmPGE2 are able to contribute to 
hematopoiesis for at least 3 months following transplantation, long after control cells 
have depleted.   
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Figure 23:  Schematic of 5-FU-treated donor transplants  
 
Whole bone marrow is harvested from donor mice that were treated with either 5-FU or PBS 2 days before 
transplant.  Cells are treated ex vivo with DMSO or dmPGE2 before transplantation along with competitor 
marrow. 
 
 
Figure 24:  dmPGE2 enhances repopulation following 5-FU treatment 
 
Total donor marrow chimerism was analyzed in recipients of mice 4 weeks (left graph) and 12 weeks (right 
graph) post transplant.  Donor cells were treated with DMSO (filled bars) or dmPGE2 (open bars).  The x 
axis illustrates if donor mice were treated with PBS or 5-FU prior to transplant.  
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PGE2 induces a quiescent gene signature in human CD34+cells  
 Microarray analysis of human UCB CD34+ cells treated with dmPGE2 revealed 
differentially regulated genes that play a role in cell surface receptor signal transduction, 
cell proliferation and migration49.  This gene signature was confirmed using RNA 
sequencing on CD34+ cells (V. Binder, unpublished data).  PGE2 robustly activates 
cAMP signaling in CD34+ cells through EP2 and EP4 receptors.  We therefore performed 
ChIP-sequence analysis for activated cAMP response element-binding protein (pCREB) 
in human CD34+ cells. CREB is a transcription factor that binds cAMP response 
elements (CRE) on DNA. Using gene set enrichment analysis (GSEA), we compared 
genes that are up-regulated by PGE2 and bound by pCREB to published gene lists known 
to be involved in quiescence.  Human CD34+ cells were mobilized and FACS-sorted for 
microarray analysis of quiescent and cycling cells115.  We found a strong correlation 
between the genes that are up-regulated in quiescent cells and genes that are up-regulated 
by dmPGE2 treatment (Figure 25).  In addition, close to half of the up-regulated genes in 
quiescent CD34+ cells are bound by pCREB after dmPGE2 treatment.  A recent study in 
mice identified a set of genes that is down regulated in HSCs after just one cell division, 
which correlates with diminished repopulation potential116.  GSEA shows genes that are 
specifically down following cell division are up-regulated when treated with PGE2 
(Figure 25).   
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Figure 25: GSEA shows significant enrichment of quiescent gene expression by dmPGE2 
Enrichment plots for mouse (left) and human (right) gene sets that have been previously associated with 
HSPC quiescence. FDR and p-value are all <0.05 and Normalized Enrichment Score (NES) = 1.4 (left) and 
2.6 (right). ChIP-seq analysis shows that 33% (left) and 46% (right) of the genes in the leading edge are 
bound by pCREB in the presence of dmPGE2. 
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Discussion 
 Our studies demonstrate that pulse exposure of dmPGE2 enhances long-term 
repopulation of HSPCs.  Using a runx1:GFP zebrafish transgenic line, we have shown 
that treatment with dmPGE2 during development increases the number of embryonic 
HSPCs; an effect that is maintained through adulthood.  This HSPC pool has improved 
engraftment and reconstitution in competitive transplantation assays, suggesting dmPGE2 
increases functional HSPCs.  However, this advantage is most likely attributed to an 
overall increase in cell number, rather than cell intrinsic memory from a signal.  In 
contrast, mouse studies indicate that PGE2 preferentially enhances the function of ST-
HSCs, without affecting cell number.  PGE2 may induce a quiescent gene signature in 
this population that is normally found in more potent LT-HSCs.   
 Variations in experimental systems could account for the different effects of 
dmPGE2 treatment on HSPCs.  Zebrafish whole embryos are treated in vivo for a 24-hour 
developmental window, during which HSCs are being specified.  In contrast, adult mouse 
marrow cells are treated ex vivo for 2 hours.  Our methods of identifying HSPCs in 
zebrafish and mouse also differ greatly.  Currently in the zebrafish, the runx1:GFP 
transgenic line is the most specific tool for isolating HSCs; however this population of 
cells most closely resembles that of LSK in the mouse.  It is possible that PGE2 does 
preferentially affect a subset of runx1+ HSPCs that resembles the ST-HSC pool in mice, 
however we cannot distinguish this population with our current system.         
 There is a distinction between ex vivo and in vivo treatment of dmPGE2 in mice.  
Prolonged in vivo exposure to dmPGE2 leads to increased proliferation and repopulation 
capacity of ST-HSCs/MPPs, followed by subsequent exhaustion and loss of 
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differentiation potential.  Continuous exposure to dmPGE2 may induce multiple rounds of 
excessive proliferation from which cells cannot recover.  Patients with mutations in the 
prostaglandin transporter gene, SLCO2A1, have elevated levels of circulating PGE2, 
which eventually leads to pancytopenia with bone marrow hypocellularity117.  In addition, 
EP receptors have been shown to internalize upon constant stimulation, which would 
alter the response to PGE2.  In contrast, ST-HSCs treated ex vivo with a brief pulse of 
dmPGE2 exhibit enhanced, long-term repopulation and do not deplete up to 1-year post 
transplant.  These results have important clinical implications, as the latter treatment 
protocol is more amenable for human transplantation studies.   
 Transplant recipients are at high risk for infection until they have a fully 
reconstituted hematopoietic system. PGE2 improves the homing and repopulation 
capacity of UCB donor cells, making it a valuable clinical resource.  ST-HSCs/MPPs that 
are proliferative and actively cycling are the first cells to contribute to hematopoiesis 
following transplantation and are therefore critical for the initial recovery of 
myeloablated patients.  Clonal analysis suggests that contribution from this progenitor-
like pool is transient; once these cells exhaust, LT-HSCs provide long-term reconstitution 
(J. Sun, unpublished). PGE2 has a protective effect on cycling cells, specifically ST-
HSCs, which may delay or prevent exhaustion and enable long-term contribution.  Our 
studies show that PGE2 treatment improves transplantation by conferring the advantages 
of ST-HSCs and LT-HSCs—rapid contribution to hematopoiesis and long-term 
reconstitution—on ST-HSCs alone. 
 GSEA demonstrates that genes which are up-regulated by PGE2 are enriched for 
genes associated with HSPC quiescence in human and mice.  In addition, many of these 
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genes are targets of CREB, and are bound by pCREB following dmPGE2 treatment.  
Interestingly, about 60% of pCREB- bound sequences contain Runx1 binding motifs. We 
also observed that Runx1 target genes appear to be enriched in PGE2- up regulated gene 
lists.  Runx1 plays a critical role in adult hematopoiesis44 and is required for HSC 
specification during embryogenesis43.  Although not required for adult HSC self-renewal, 
Runx1-deficient HSCs display dysregulated cell cycle and cell survival pathways118.  It 
will be interesting to compare the overlap of pCREB target genes with those of other 
transcription factors regulating HSC self-renewal and function.  PGE2 may prevent 
exhaustion of cycling cells that are contributing to hematopoiesis by inducing a quiescent 
gene signature.  
 Clonal tracking of HSCs in mice and non-human primates demonstrates that 
short-term clones repopulate the majority of mature blood immediately following 
transplantation119.  After time, these short-term clones exhaust and are replaced by long-
term clones that provide multi-lineage reconstitution for the duration of the organism’s 
life.  We hypothesize that treatment with dmPGE2 extends the period of time post-
transplantation that short-term clones can effectively contribute to the blood pool. A 
model to explain the enhanced transplantation potential of cells treated with dmPGE2 is 
summarized in figure 26.  The improved repopulation effect of dmPGE2 on short-term 
HSCs may be enhanced by the additional support of long-term clones, however this has 
yet to be tested.  Treatment of human cord blood cells with dmPGE2 induces a gene 
signature that is enriched in quiescent cells, presumably through activation of 
intracellular cAMP and associated transcription factors such as CREB and CREM.  
Induction of genes that are important for quiescence may support the maintenance of 
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short-term clones post-transplantation by improving engraftment potential, or preventing 
exhaustion of contributing cells.  Additional experimentation should identify the specific 
genes required for this effect.      
    Identifying a population of human cord blood cells that is specifically affected by 
dmPGE2 treatment will have important clinical implications.  Improving expansion 
protocols prior to transplantation may decrease the number of required units and increase 
the availability of donor cords.  In addition, further characterization of the specific genes 
induced by dmPGE2 treatment may give us additional insights into fundamental 
mechanisms regulating HSC self-renewal and function. !!!!!!
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Figure 26: Summary model of dmPGE2 effect on HSC repopulation 
 
The top panel represents a normal transplantation setting after HSPCs are transplanted into irradiated 
recipients.  Initially, short-term clones give rise to all mature blood cells in the peripheral blood.  Once 
these clones exhaust, long-term clones take over and reconstitute the hematopoietic system.  The bottom 
panel shows that when HSPCs are treated with dmPGE2, short-term clones give rise to multilineage 
reconstitution for an extended time post-transplantation.  This effect is potentially due to an induction of 
genes associated with quiescence in these ST cells.    
!!!!
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Concluding Discussion: 
Generation of a specific HSPC transgenic zebrafish line 
 We have developed a novel HSPC-specific transgenic zebrafish using a regulatory 
element that is +23 kb downstream of the ATG in the first promoter of mouse Runx1 to 
drive expression of a reporter79.  Time-lapse live imaging showed that Runx1+ cells 
emerge from the hemogenic endothelium of the dorsal aorta, enter circulation, and seed 
the CHT, where definitive hematopoiesis first occurs.  FACS analysis and cytospins 
confirmed that these cells are spherical with a high nucleus to cytoplasmic ratio, which is 
consistent with the morphology of murine HSCs.  We developed an embryonic 
transplantation assay to calculate the frequency of HSCs in Runx1:GFP embryos.  
Embryonic limit dilution analysis estimated the stem cell frequency of the Runx1+ 
population in the 3 dpf embryo to be approximately 1/2.88 cells.  A number of studies 
have shown that hematopoietic stem cells isolated from different tissues of the mouse 
embryo have the capacity to reconstitute hematopoiesis in the adult84,90,91.  However, 
technical limitations in mouse have made it difficult to assess the stem cell potential of an 
HSPC transplanted from one embryo to another.  Our studies are the first to document the 
functional capacity of embryonic HSPCs in an embryo transplant. 
 FACS analysis of adult kidney marrow confirmed that Runx1+ cells go on to seed 
the adult niche.  These cells give rise to long-term multilineage reconstitution when 
transplanted into irradiated recipients.  This is consistent with studies in mice that 
demonstrate Runx1+ fetal liver cells successfully transplant into adult mice.  Through 
adult limit dilution analysis of Runx1+ cells, we calculated a stem cell frequency of 
approximately 1/35. This is most likely an underestimate as zebrafish donors and 
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recipients are non-isogenic and are therefore not immune matched, which leads to 
immune rejection of some donor cells. Currently there are no antibodies available in 
zebrafish to further purify this population, or to distinguish between a stem cell and a 
progenitor.  Our results demonstrate that the HSPC pool in zebrafish can be sorted with a 
single transgenic marker to a purity that is within the range of the well-characterized LSK 
(Lin-Sca1+cKit+) population in mouse89.  Our characterization of the Runx1 transgenic 
line, including a novel embryo transplantation assay and limiting dilution transplantation 
in adults, demonstrates that Runx1+ cells mark a highly purified HSPC population with 
functional stem cell characteristics. 
 
Live imaging reveals a novel endothelial cell behavior during stem cell colonization 
 We performed time-lapse live imaging of Runx1:GFP embryos and directly 
observed distinct steps of HSPC engraftment, including a novel cellular behavior of 
remodeling endothelial cells.  Upon entering circulation from the dorsal aorta, Runx1+ 
cells adhered to endothelial vessel walls in the CHT and underwent rapid extravasation to 
the abluminal side of the endothelial wall.  Once an HSPC lodged in the CHT, a small 
group of endothelial cells remodeled around the stem cell to form a closely associated 
niche.  This niche formation event was typically completed in 30-60 minutes and was 
marked by a single HSPC surrounded by a group of 5-6 endothelial cells.  Through live 
imaging, we found that endothelial cell niche remodeling is conserved in fetal liver 
explants. Ly6a-GFP+/c-kit+ HSPCs underwent discrete steps towards lodgement: 
adherence, extravasation, abluminal migration, and endothelial niche remodeling.  
  3D reconstruction of high-resolution serial section electron microscopy scans 
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confirmed that HSPCs lodged in the CHT are surrounded by 5-6 endothelial cells. There 
are also stromal cells in proximity to the HSPC, which is consistent with our confocal 
microscopy of Runx1+ HSPC and cxcl12a+ stromal transgenic lines.  Cell types not 
observed by confocal microscopy, including a fibroblastic mesenchymal cell with 
melanophore inclusions, were found together with the HSPC, endothelial cells and 
stromal cells.  Melanophore inclusions are indicative of neural crest origin, and such cells 
have been found in the adult marrow71,120,121.  HSPC-endothelial cell niches were 
heterogeneous, but the formation of niches was specific to more primitive HSCs.  Our 
high-resolution reconstruction of a zebrafish HSPC niche recapitulates many features of 
the perivascular niche in mice, which contains a diverse set of cell types including 
mesenchymal stem and progenitor cells, endothelial cells, and nerves.  An advantage of 
our system is the ability to observe dynamic interactions of these cell types in vivo.    
 After remodeling of endothelial cells, HSPCs made one of three cell fate 
decisions: it remained quiescent, underwent symmetrical division, or it divided 
asymmetrically where one daughter cell exited the endothelial niche.  Similarly, we 
observed in fetal liver explants that Ly6a-GFP+/c-kit+ HSPCs underwent cell divisions 
where the daughter cell proximal to the sinusoid remained surrounded by endothelial 
cells, while the daughter cell distal to the sinusoid migrated away into the abluminal 
space.  Zebrafish CHT endothelial cells do not directly differentiate into budding HSPCs, 
as is seen in the hemogenic endothelium of the dorsal aorta. This is consistent with the 
model that the CHT is equivalent to fetal liver and is not a site of de novo stem cell 
production122 but instead must be seeded by HSPC arriving through circulation123.   Our 
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studies provide dynamic observations of HSPC niche interactions during development 
that reveal a novel endothelial cell remodeling.   
  
Chemical genetics reveals small molecule regulators of CHT niche colonization 
 Treatment of zebrafish embryos with AMD3100 reduced the number of HSPCs in 
the CHT.  This is consistent with the role of CXCR4-CXCL12 signaling during adult 
homing and engraftment and served as a proof-of-principle for the screen.  A chemical 
screen identified 147 compounds that regulate CHT hematopoiesis.  We combined 
selected chemical hits together with our live imaging assay to associate specific signals 
with the distinct engraftment steps we previously described.  One screen hit, a selective 
inhibitor of TGF-! type I receptors, SB-431542, increased CHT hematopoiesis via 
increased frequency of HSPC cell divisions.  HSPCs arrived normally in the CHT and 
adhered to the vessel wall, but before each cell engrafted, they underwent excessive 
rounds of division.  These data illustrate that inhibition of TGF-! receptor signaling 
expands the HSPC population by causing extra cell divisions.  This is consistent with 
previous studies for the role of TGF-! in quiescence that show knock down of TGF-! in 
mice results in excessive HSC proliferation95. 
 Another hit from the screen DMOG, which stabilizes HIF-1# under normoxic 
conditions124, increased the number of runx1+ cells in the CHT by altering HSPC 
localization.  HSPCs in DMOG-treated embryos extended protrusions into the abluminal 
space and preferentially migrated to those regions.  The HIF-1# inhibitor YC-1 also 
increased HSPCs in the CHT, but these cells were retained in the vessel lumen.  Our data 
suggest HIF-1# stability and a hypoxic state promotes HSPC migration into abluminal 
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spaces within the niche. HIF-1# is expressed in the zebrafish CHT (Rojas et al., 2007).  
Consistent with our results, HIF-1# is an important HSPC maintenance factor in 
mammals.  HIF-1#-deficient HSCs exhibit excessive proliferation, and overstabilization 
of HIF-1# reduces the transplantation potential of HSCs125. 
  We identified lycorine, a natural alkaloid extracted from the Amaryllidaceae plant 
family, as a novel regulator of hematopoiesis.  Treatment with lycorine increased CHT 
hematopoiesis by retaining HSPCs in the niche.  Time-lapse imaging confirmed that 
lycorine treatment increased the number of HSPCs that resided in endothelial cell niches, 
as well as the total duration each HSPC spent in the CHT.  The increased number of 
HSPCs observed in the CHT is maintained after treatment.   Together, these results 
demonstrate that lycorine treatment modulates the number of endothelial niches that are 
triggered upon HSPC arrival in the CHT, and also the time that HSPC stay within these 
niches.  
 Several chemicals that regulate the sphingosine-1-phosphate (S1P) pathway 
induced alterations in the migration pattern of HSPCs.  Consistent with our results,   
S1P is an important signal in adult HSPC and lymphocyte trafficking126.  Embryos 
injected with s1pr1 morpholino had reduced numbers of HSPCs in the CHT.  S1PR1-
deficient HSPCs were unable to extravasate into the CHT after adherence to the 
endothelial wall.  These experiments support a cell autonomous role for s1pr1 in HSPC 
extravasation during colonization of the CHT.  We and others106,107 have demonstrated 
that combination of S1P agonists and CXCR4 antagonists facilitates HSC mobilization 
from the niche in a G-CSF-independent manner.  These results suggest that the current 
standard of G-CSF mobilization in patients could be improved by manipulation of the 
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S1P/CXCR4 signaling axis.  Our chemical screen demonstrates the ability to modulate 
HSPC- endothelial cell interactions, at several key steps, and will likely have an 
important impact on clinical stem cell transplantation. 
    
      Short-term exposure of PGE2 enhances long-term repopulation of the HSPC pool 
 A similar chemical screen identified PGE2 as a regulator of HSPCs in the AGM.  
Zebrafish embryos treated with dmPGE2 during embryogenesis displayed an increase of 
Runx1+ cells in the AGM, CHT, and adult kidney marrow, without additional treatment.  
Whole kidney marrow from treated fish demonstrated improved repopulation compared 
to control cells in competitive transplantation assays.  However, Runx1+ cells did not 
demonstrate an advantage during transplantation on a cell-by-cell basis. These results are 
consistent with murine transplantation experiments in which equal numbers of LSK 
SLAM cells from primary recipients mice did not demonstrate an advantage of dmPGE2 
treatment in secondary transplants108.  Our data suggest that zebrafish treated in vivo with 
dmPGE2 results in a long-term repopulation advantage due to an increase in the Runx1+ 
pool, rather than a change in inherent cell competitiveness.  Mouse marrow cells treated 
ex vivo with a short pulse of dmPGE2 displayed improved repopulation capabilities 
compared to control cells in primary transplants.  Increased peripheral blood chimerism 
levels were maintained in recipients up to 1-year post transplant.  Treated cells continued 
to demonstrate a transplantation advantage in secondary recipients without additional 
dmPGE2 treatment.  This is consistent with previous transplantation studies that show a 
single pulse with dmPGE2 improves the repopulation capacity of HSPCs through quinary 
transplants46,108.  Collectively, our results demonstrate that just a brief (2-hour) ex vivo 
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exposure of WBM cells to dmPGE2 confers long-term repopulation advantage that is 
maintained through multiple rounds of transplantation, however this is not due to 
improvement in inherent cell function of LT-HSCs.  
 
PGE2 preferentially affects ST-HSCs and prevents exhaustion of cycling cells 
 We found that treatment with dmPGE2 enhanced long-term repopulation by 
modulating a population of ST-HSCs that are phenotypically LSKCD34+CD150+.  
FACS-sorted ST-HSCs treated with dmPGE2 displayed improved reconstitution in 
recipients that was stable 1-year post transplantation, and was maintained through 
secondary transplantation.  This advantage was specific to the ST-HSC compartment; 
there was no improvement in repopulation of dmPGE2-treated LT-HSCs or MPPs.  The 
effect of dmPGE2 on the repopulation capacity of ST-HSCs was significantly enhanced 
following negative selection of CD48 expression.  CD48+ cells account for close to 30% 
of LSKCD34+CD150+ cells.  This illustrates the heterogeneity of purified HSPCs and 
suggests that PGE2 affects a small subset of the ST-HSC population.   
 A study by the Calvi lab demonstrated that mice continuously treated in vivo with 
dmPGE2 displayed specific expansion of the ST-HSC/MPP pool47.  Sorted ST-
HSCs/MPPs from treated mice quickly lost repopulation potential following 
transplantation, suggesting these cells exhausted.  It has been previously described that 
LSKCD34+ cells have only transient multilineage potential that is lost by ~12 weeks-post 
transplant27.  In contrast, we demonstrate that ex vivo pulse treatment with dmPGE2 
confers long-term repopulation capabilities on ST-HSCs that are maintained through 
serial transplantation.  
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 We performed transplants with mice treated with 5-FU as donors to test the effect 
of dmPGE2 on cycling cells.  Previous work showed that dmPGE2 treatment increased the 
percentage of cycling cells in vitro in all HSC populations46.  It is not known how PGE2 
affects cell cycle kinetics in vivo, or whether it preferentially acts on cells that are 
proliferating or quiescent. Cells treated with dmPGE2 performed better in both 
experimental groups (5-FU or PBS).  Mice that received cells from 5-FU-treated donors 
displayed decreased chimerism levels, irrespective of treatment group, compared to PBS 
controls at 4 weeks-post transplant.  This is consistent with previous studies that 
demonstrate the impaired repopulation potential of 5-FU-treated cells114.  Recipient mice 
in the 5-FU/dmPGE2 group showed higher chimerism levels than PBS controls at 12 
weeks-post transplant. These data suggest that cycling HSCs treated with dmPGE2 
robustly contribute to hematopoiesis for at least 3 months following transplantation, long 
after control cells have depleted.  Collectively, our data suggest that ex vivo pulse 
treatment with dmPGE2 prevents exhaustion of ST-HSCs and facilitates long-term 
reconstitution following transplant. 
 
PGE2 induces a quiescent gene signature in human CD34+cells  
 We found a strong correlation between genes that are up-regulated in quiescent 
HSCs and genes that are up-regulated by dmPGE2 in human CD34+ cells.  RNA 
sequencing of human CD34+ cells treated with dmPGE2 revealed an induction of genes 
involved in cell surface receptor signal transduction (FOS, PTGER4, S1PR1), cell 
proliferation (TGFB2, PTGS2), and migration (CXCR4, S1PR1).  We find a high degree 
of overlap with published microarray gene lists of dmPGE2-treated human CD34+ cells.  
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PGE2 robustly activates cAMP signaling in CD34+ cells through EP2 and EP4 
receptors48.  We identified a subset of genes that are bound by activated cAMP response 
element-binding protein (pCREB) following dmPGE2 treatment in human CD34+ cells.  
GSEA demonstrated a strong correlation between previously defined genes that are up-
regulated in quiescent cells, and genes that are differentially expressed and bound by 
pCREB following dmPGE2 treatment.   
 A recent study developed a novel label retention Tet-off system in mice to 
monitor the cell division history of HSPCs116.  In their system, HSPCs take up H2B:GFP 
until Dox is administered.  Following Dox chase, label retention is assessed to determine 
the cycle history of HSPCs.  HSCs that have previously undergone cell division have 
greatly impaired repopulation capabilities compared to cells that were previously 
quiescent.  The authors identified a set of genes that are significantly down regulated 
following HSC division.  GSEA demonstrated these genes are enriched in the gene 
signature induced by dmPGE2 treatment in human CD34+ cells.  Our data suggest that 
PGE2 induces a gene signature associated with quiescent cells that have high repopulation 
potential.  This is a potential mechanism by which PGE2 prevents exhaustion in cycling 
cells, such as the ST-HSC population. 
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Concluding Remarks  
 In this thesis, we have studied and characterized the endogenous 
microenvironment and trafficking of zebrafish HSPCs in the niche.  We developed a 
novel zebrafish transgenic reporter line that enabled us to visualize and purify HSPCs.  
This line was used to observe a novel and essential cellular behavior that involves 
triggered remodeling of perivascular endothelial cells upon arrival of an HSPC in a new 
site of hematopoiesis.  Live imaging of fetal liver explants confirmed that this endothelial 
remodeling effect is conserved in mammals. 
 Using runx1:GFP zebrafish, we observed a long-term effect of PGE2 on 
hematopoiesis that is conserved in mammals; WBM cells treated with PGE2 maintain 
increased chimerism levels in recipient mice over 1-year post transplantation and display 
enhanced transplantability in competitive secondary transplantations without additional 
PGE2 treatment.  We demonstrate that PGE2 affects a population of HSPCs that was not 
previously thought to have long-term repopulation potential.  Gene expression data and 
ChIP-seq analysis in human CD34+ cells suggests that PGE2 may protect cycling cells 
from exhaustion by inducing a quiescent gene signature in these cells.   
 Our studies provide a glimpse into the dynamic interactions between HSPCs and 
their endogenous niche.  In addition, we show that a population of short-term HSCs can 
engraft and give rise to long-term multilineage reconstitution following dmPGE2 
treatment.  Collectively, we have gained novel insights in the pathways involved in HSC 
migration, homing, and repopulation. 
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Future Directions 
Improving HSC purification in zebrafish 
 We described a novel transgenic zebrafish that we could use to follow HSPCs 
during migration.  Adult limit dilution analysis estimated a stem cell frequency of 
approximately 1/35.  This is a dramatic enhancement of purity over previously identified 
markers of zebrafish HSPCs such as cmyb and CD41.  However, this level of purity 
could most likely be improved upon, especially considering that murine HSCs can be 
isolated at a frequency closer to 1/2.  CD41 marks two populations of zebrafish blood 
cells; CD41hi expressing cells are thrombocytes and CD41lo expressing cells are 
transplantable HSPCs127.  In addition to HSPCs, Runx1 also marks a population of 
thrombocytes.  This suggests CD41 as a potential secondary marker for further purifying 
zebrafish HSCs.  HSPCs from Runx1:mCherry/CD41:GFP double transgenic fish could 
be sorted out to compare the transplantation efficiency of Runx1+CD41lo and 
Runx1+CD41- cells to Runx1+ cells alone.  Limit dilution analysis of each population 
would confirm if CD41 further purifies the stem cell frequency of the Runx1+ HSPC 
pool.  I would expect that a population of Runx1+/CD41lo cells would have a higher stem 
cell frequency than Runx1+ cells alone.  However, it is unlikely that these two markers 
alone will demonstrate purity close to that of LT-HSCs in mice.   
 We have performed microarrays on sorted embryonic Runx1+ HSPCs and Flk1+ 
endothelial cells, which may implicate other genes that distinguish HSCs from other cell 
types in the embryo.  We also looked at gene expression of Runx1+ cells at different 
stages of development.  Since we know that adult Runx1+ cells retain HSPC function, 
genes that are common across all time-points will be of particular interest.  HSPC-
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specific genes can first be tested in co-expression studies with Runx1+ cells, and 
eventually transplantation assays.  Currently there are no antibodies available in zebrafish 
to further purify HSPCs, or to distinguish between a stem cell and a progenitor.  
Improved purification of HSCs combined with the strengths of the zebrafish system 
would be beneficial to the field, and is especially important for our niche studies, as we 
may uncover unique niche dynamics that are specific to different HSPC subpopulations. 
 Finally, it will be interesting to identify the developmental stage at which 
definitive HSPCs are mature enough to repopulate adult recipients.  Runx1+ cells could 
be sorted at different developmental stages and transplanted into adult recipients.  This 
will determine whether maturation in the CHT is sufficient for HSPCs to maintain adult 
hematopoiesis.  If HSPCs in the CHT cannot repopulate adult recipients, it is likely that 
further maturation is required in the kidney marrow, the next site of hematopoiesis. 
 
Testing downstream functional consequences of niche perturbations 
 We identified several compounds that affect endogenous HSPCs in their 
interaction with the niche microenvironment.  However, we do not know what 
subsequent functional consequences these perturbations may have on HSPCs.  An 
important follow-up study would be to elucidate the downstream effects of altering 
HSPC-niche interactions.  Zebrafish embryos can be treated with chemicals that we 
previously described to affect distinct stages of engraftment, such as: SB-431542, 
DMOG, lycorine, and S1P agonists.  During treatment, embryos could be imaged using 
confocal microscopy to confirm the affected phenotype.  Following CHT colonization, 
chemical would be washed off and fish would be grown to adulthood.  HSPC migration 
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and colonization of the kidney marrow could be assayed using FACS analysis for Runx1+ 
cells.  In this assay, it is possible to observe the presence or absence of Runx1+ cells, as 
well as determine the number of HSPCs.  To test the functionality of these cells, Runx1+ 
cells could be sorted out and transplanted into irradiated recipients.   
 I would expect that a TGF-! inhibitor, like SB-431542, might lead to increased 
numbers of Runx1+ cells in the kidney marrow due to excessive proliferation, but that 
these cells would not perform as well in a functional transplantation assay.  If DMOG 
also affects the localization of Runx1+ cells in the kidney marrow, the total number of 
HSPCs will be increased.  Similarly, I expect that these cells will have decreased 
repopulation capacity since stabilization of HIF-1# in the mouse reduces transplantation 
potential of HSCs.  Lycorine demonstrates a similar effect to PGE2; a pulse treatment 
results in increased numbers of Runx1+ cells long after the chemical is washed off.  
Based on our PGE2 results, I would expect that lycorine-treated embryos would have 
higher numbers of HSPCs in kidney marrow, but would not have altered repopulation 
potential on a cell-by-cell basis. 
 It is also possible that chemical treatment during CHT colonization will not affect 
later stages of adult hematopoiesis.  Instead, we can treat adult fish with these chemicals 
to determine if they directly play a role in mediating adult HSPC-niche interactions. In 
this experiment, we can also look at peripheral blood of treated fish.  If any chemicals 
induce mobilization of HSPCs, we would detect Runx1+ cells in circulation.  The 
combination of time-lapse live imaging and chemical genetics in zebrafish embryos 
allowed us to identify novel chemicals that affect different and distinct aspects of HSPC 
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migration and colonization.  We can now test these chemicals on endogenous adult 
HSPCs and their microenvironment.  
    
Characterizing additional cell types that interact with HSPCs in the niche 
 Confocal microscopy of Runx1:GFP; cxcl12a:DsRed double transgenic lines 
demonstrated that Runx1+ HSCPs are in close proximity to stromal cells in the CHT.  
Therefore, it would be interesting to repeat live imaging studies with our previously 
identified chemicals using Runx1:GFP; cxcl12a:DsRed fish.  In particular, chemicals that 
mediate the localization of HSPCs may modify the architecture of HSPC-stromal 
interactions.  Future studies should also focus on visualizing how Runx1+ HSPCs interact 
with multiple niche cells at once.  Additional transgenic lines for Flk1, cxcl12a, and 
nestin should be generated driving CFP or far red expression so that more cell types can 
be visualized.  Chemical treatments of these embryos would give a more complete picture 
of HSPC niche dynamics. 
 We used high-resolution serial section electron microscopy (EM) scans to better 
reveal cellular interactions between HSPCs and the niche.  As predicted from our 
confocal microscopy analysis, the HSPC is surrounded by at least 5 endothelial cells with 
stromal cells in close proximity to the HSPC.  EM revealed an additional cell type that 
was not detected by confocal microscopy.  A fibroblastic mesenchymal cell, with what 
appears to be melanophore inclusions, was found together with the HSPC, endothelial 
cells, and stromal cells.  An important future experiment is to repeat EM scans on 
embryos that have been treated with chemical.  The benefit of this experiment is two-
fold: treated embryos that display the expected CHT phenotype can be pre-selected 
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before EM scanning, which will give high resolution detail of the perturbed endothelial 
cell remodeling event.  Secondly, EM scans will provide a more complete picture of 
additional cell types in the niche that cannot be visualized using confocal microscopy.  
Lastly, analysis of more EM scans will determine whether this remodeling event is 
specific to Runx1+ HSPCs in the CHT.  There is dynamic cellular migration and 
trafficking in the CHT during this stage of development.  I expect that our observed 
endothelial remodeling event is specific to HSPCs that are lodged in the CHT, as opposed 
to more mature hematopoietic cells.  The combination of these two microscopy tools will 
be a powerful assay for piecing together the endogenous microenvironment of HSPCs.   
 
Identifying genes that are targets of PGE2 in ST-HSCs  
 GSEA on data from RNA sequencing, microarray, and ChIP sequencing analysis 
identified a correlation between genes that are up-regulated and bound by pCREB in the 
presence of dmPGE2, and genes that are up-regulated in quiescent cells.  The majority of 
this data is from human CD34+ cells, and therefore future work should focus on 
discovering specific gene targets of PGE2 in the ST-HSC population.  Previous 
microarray experiments on sorted LT-HSCs, ST-HSCs, and MPPs treated with or without 
dmPGE2 were inconclusive in identifying a PGE2-induced gene signature.  Microarray 
experiments should be repeated, with minor changes to the previous protocol.  Cells were 
harvested, stained and sorted for different HSPC populations (LT/ST/MPP), and treated 
with dmPGE2 or DMSO for 2 hours on ice before RNA collection.  It is possible that a 2-
hour treatment on ice is not conducive to observe differential gene expression.  In 
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addition, cells may need a “rest” period between sorting and chemical treatment, as they 
might already be in an activated stress state. 
 It is possible that our population of ST-HSCs (LSKCD48-CD34+CD150+) remains 
heterogeneous.  If PGE2 only affects a small subset of these cells, we might not detect 
expression changes on whole genome microarray.  Single-cell PCR experiments could be 
performed using a successful protocol that was developed by the Orkin lab.  This would 
enable us to test the heterogeneity of response of sorted cell populations to dmPGE2 
treatment at the single cell level.  PGE2-regulated genes identified from human CD34+ 
cells should be tested, as well as known mouse lineage genes.  Although we did not 
identify a dmPGE2 signature specific to ST-HSCs in microarray experiments, we 
discovered genes that are differentially regulated between LT-HSCs, ST-HSCs, and 
MPPs.  It will be important to test genes from this list, as we are using a unique antibody 
combination to most published expression analyses.   
 Once genes have been identified that are regulated by PGE2 in ST-HSCs, they 
should be tested in functional assays.  If the gene list is large, morpholino knock-downs 
or CRISPR in fish could serve as a mini screen to test target genes.  Runx1:GFP zebrafish 
embryos would be injected with morpholino to the gene of interest, and treated with 
dmPGE2.  Runx1+ cells would be assayed in the AGM of 36hpf zebrafish.  If a particular 
gene is necessary for PGE2-mediated increase of Runx1+ cells, Runx1 expression will 
resemble control embryos, or might be decreased.  Genes that are found to inhibit the 
effect of dmPGE2 treatment on Runx1+ cells in the fish (or the initial gene list if it is 
small) should be tested in mouse transplantation assays.  Sorted ST-HSCs would be 
infected with a single shRNA designed to target the candidate gene list.  Following 
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infection, cells would be treated with dmPGE2 or DMSO and transplanted into irradiated 
recipients.  After 24 weeks, long-term reconstitution will be assessed by PB chimerism.  
If a gene is specifically required for enhanced repopulation by PGE2, those recipients will 
display chimerism levels similar to control cells.  It is possible that certain genes may be 
required for normal reconstitution; knockdown of these genes would show an effect in 
transplant of DMSO-treated cells.  These experiments will identify genes that are 
regulated by PGE2 in ST-HSCs, and are required for its effect on HSC function.      
 
Investigating epigenetic regulation of HSCs by PGE2 
 
 The long-term transplantation effects of a brief pulse of dmPGE2 could, in part, be 
mediated by epigenetic changes.  It is possible that PGE2 induces a stable change in 
epigenetic state that enables long-term repopulation by ST-HSCs.  PGE2 has been shown 
to affect DNA methylation patterns in the intestine and increases global DNA 
methylation via induction of DNMT3a in fibroblasts128.  To test the effect of dmPGE2 on 
DNA methylation in zebrafish, Runx1+ cells from treated embryos would be sorted out at 
different stages following treatment.  Whole-genome bisulfite sequencing could be used 
to identify changes in DNA methylation.  Alternatively, methylation analysis could be 
performed solely on the previously identified gene list.  It would be interesting to follow 
methylation patterns at different times post-treatment.  Runx1+ cells would most likely 
acquire changes in DNA methylation on some HSC maintenance or survival genes 
induced by dmPGE2 treatment.  This methylation pattern would still be observed in adult 
Runx1+ cells.  In addition, DNA methylation analysis can be performed on sorted mouse 
marrow populations as well as human CD34+ cells. It would be interesting to compare 
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methylation changes in zebrafish, induced by in vivo treatment during embryogenesis, 
and mouse or human cells, which are pulse-treated ex vivo. DNMT3a regulates HSC 
differentiation in mice, and is highly enriched in primitive HSC populations129.  Based on 
data from other systems, it is likely that dmPGE2 will affect the methylation status of 
these cells.  Epigenetic mechanisms are the most likely candidate to explain the long-term 
effects of PGE2 on HSPC function.   
 
Investigating PGE2 and cycling cells     
 dmPGE2 treatment increases the percentage of cycling cells in vitro in all HSC 
populations, but it is not known how PGE2 affects cell cycle kinetics in vivo, or whether it 
preferentially acts on cells that are proliferating or quiescent.  A recent study by Qui et al 
demonstrates that current methods of analyzing cell cycle, such as Ki67, Hoescht, and 
Draq5 staining only provide a snapshot of the quiescent state of a cell that is not always 
indicative of a cell’s cycling history116.  Using an inducible, GFP label-retention 
transgenic mouse, the authors tracked cell division history of HSPCs.  This system 
enables cells to be analyzed based on current quiescent state, as well as cell cycle history.  
Our initial transplantation experiments showed a modest effect of dmPGE2 treatment on 
LSKCD34+CD150+ cells that was significantly enhanced when the population was further 
purified using CD48 expression.  Interestingly, Qui et al found that negative selection of 
CD48 enriches for a more dormant HSC population (0.19% of LSKCD48+CD150- cells 
are highly quiescent, compared to 3.37% of LSKCD48-CD150- cells).  
 Future experiments should test if PGE2 preferentially affects quiescent or cycling 
cells.  Using this transgenic mouse system, LSKCD48-CD34+CD150+ ST-HSCs can be 
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split into highly dormant and more active HSCs based on their levels of GFP retention.  
Each population would be treated with dmPGE2 or DMSO and compared in repopulation 
assays.  Chimerism analysis would reveal if PGE2 preferentially acts on one of these cell 
populations, as they are phenotypically identical.  To determine if PGE2 acts 
preferentially on cells that are actively cycling, LSKCD48-CD34+CD150+ ST-HSCs 
stained with Draq5 can be sorted into different cycling populations based on DNA 
content.  These experiments will provide insight into the cell population that is affected 
by PGE2.  Identifying a population of HSPCs that is specifically affected by dmPGE2 
treatment will have important clinical implications. A phase 1 trial was recently 
completed to test expansion and subsequent transplantation of cord blood HSCs 
following ex vivo dmPGE2 exposure.  Improving expansion protocols prior to 
transplantation may decrease the number of required units and increase the availability of 
donor cords.  
 
Exploring additional expansion protocols for UCB cells 
 Although UCB has emerged as a valuable source of HSPCs for transplantation, 
there are limitations for its use in adult patients.  Delayed neutrophil and platelet recovery 
in adult recipients is attributed to low HSPC numbers in a single cord unit130.  Double 
cord transplantation improves the overall survival and recovery time in adult patients, but 
has an increased risk of acute GVHD131.  Recent studies have focused on developing 
expansion protocols, including chemical manipulation of UCB ex vivo, to expand HSPCs 
prior to transplant or enhance homing and engraftment of these cells following 
transplantation- reviewed in22.  Improving either of these aspects would allow more 
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patients to benefit from the advantages of cord blood transplantation.  In the future it will 
be important to investigate ex vivo expansion of UCB through chemical manipulation of 
signaling pathways, in addition to prostaglandin, that regulate HSC function.  The Notch 
signaling pathway has previously been implicated in hematopoiesis; Notch1 is expressed 
in human CD34+ cells132 and overexpression of Notch1 improves the repopulation 
potential of these cells133.  Ex vivo treatment of UCB with the notch ligand Delta1 led to 
expansion of HSPCs and shortened time to neutrophil engraftment in patients, although 
this effect was only transient134.  Future work should focus on optimizing expansion 
protocols that manipulate notch signaling in UCB.  The Wnt pathway has also been 
identified as an important regulator of HSPC function.  Treatment of UCB with 6-
bromoindirubin 3'-oxime (BIO), an inhibitor of GSK-3!, expands HSPCs ex vivo, and 
improves the engraftment and repopulation potential of these cells in immunodeficient 
mice135.  Interestingly, treatment with BIO leads to activation of notch in UCB cells, and 
may promote notch signaling during ex vivo expansion135.  In addition, prostaglandin and 
Wnt signaling pathways interact to regulate HSC function57, suggesting that targeting 
multiple pathways may enhance ex vivo expansion of UCB.       
 !
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Supplemental Information (Tamplin, Durand et al., 2014) 
 
Supplemental Figure, Table and Movie Legends 
 
Figure S1. Characterization of stable Runx:GFP and Runx:mCherry transgenic 
zebrafish lines. 
(A) Intercross of Runx:GFP and Runx:mCherry lines to show overlapping expression in 
the CHT (arrowheads). dpf: days post fertilization 
(B) Emergence of Runx:mCherry+ HSPC (red nuclei; arrowheads) in the kdrl:GFP+ 
endothelial cells (ECs) of the ventral wall of the dorsal aorta (DA; green). See Movie S1. 
hpf: hours post fertilization 
(C,E,G,I,K) Cross of Runx:mCherry and cd41:EGFP lines. (D,F,H,J,L) Cross of 
Runx:mCherry and cmyb:EGFP lines. Co-expression at stages and in embryonic sites of 
hematopoiesis as marked (i.e. thymus and CHT). We predict the larger number of 
Runx:mCherry+ cells in 3 and 5 dpf embryos are HSPC progeny. 
(M) Section of Runx:GFP zebrafish kidney stained with hematoxylin and eosin (H&E). 
(N) Immunohistochemistry of adjacent section to (M). Anti-GFP shows rare GFP+ cells 
in the kidney marrow (brown; arrowheads; counterstained with hematoxilyn). 
(O) Fluorescence-activated cell sorting (FACS) of whole kidney marrow (WKM) from 
adult Runx:GFP transgenic zebrafish. Runx:GFP+ cells represent on average 0.133% of 
the total WKM. 
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(P) Forward scatter (FSC) and side scatter (SSC) were used to distinguish characteristic 
WKM populations (Traver et al., 2003). Runx:GFP+ cells were found predominately in 
the lymphoid/HSPC gate. 
 
Figure S2. Runx:mCherry positive cells in the embryo are functional HSPC. 
(A) Summary of results from embryo-to-embryo limiting dilution transplantation 
experiments. 
(B) Embryo-to-embryo transplantation recipients with engraftment of Runx:mCherry+ 
cells in the kidney marrow at 3 months (scored if above background; >0.001%). 
(C) Representative WKM FACS plots of an embryo-to-embryo transplantation recipient 
with Runx:mCherry+ HSPC and ubi:GFP+ lineages. 
 
Figure S3. Time-lapse live imaging sequence of CHT colonization. 
See Movie S2. Selected frames of time-lapse are shown (1 frame/2 minutes). First row 
frames are a merge of Runx:GFP+ HSPC (green; second row) and kdrl:RFP+ ECs (red; 
third row in B). Times are hours:minutes post fertilization. 
(A) HSPC (arrowhead) extravasates by squeezing through endothelial wall. 
(B) ECs remodel around HSPC to form niche (broken circle). 
(C) After HSPC division the daughter cells undergo a 90º rotation (arrowheads). The 
upper cell becomes migratory and crawls out of niche. 
(D) A diagram summarizing the steps of HSPC lodgement in the perivascular niche. The 
times shown correspond to the time-lapse frames shown above. Other possible cell 
division decisions are shown. 
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Figure S4. Serial block face scanning EM of CHT after time-lapse. 
(A,B) Embryo 1 (same embryo as shown in Figure 4). Comparison of 3D projections 
from (A) confocal z-stack data and (B) serial EM scans to confirm the position of the 
lodged HSPC. (A) 3D rendered projection of z-stack (Imaris software) showing one 
lodged Runx:GFP+ HSPC (green; arrowhead) and kdrl:mCherry+ ECs (red). Scale bar: 
20 microns. (B) Vessel lumen manually outlined, surface rendered, and shown in red 
(Imaris software). 3D projection overlaid on a single EM section. Rotation performed to 
match orientation of image in (A). Orientation: D (dorsal), V (ventral), A (anterior), P 
(posterior). CA (caudal artery). Circulation is towards the posterior (left; arrow). Major 
vessels outlined. 
(C-G) Embryo 2. A second independent example of serial block face EM sections on a 
lodged HSPC after time-lapse. (C) Last frame of CHT time-lapse (60 hpf). Arrowhead 
marks HSPC lodged >6 hours. Runx:GFP green; kdrl:mCherry red; brightfield blue. 
Anterior left, posterior right, dorsal top, ventral bottom. (D) Detail of region in (C) 
marked by box. The brightness of the GFP channel was adjusted independently of the 
mCherry channel to clearly show the position of the Runx:GFP+ HSPC. Scale bar 50 
microns. (E) Single section and orthogonal slice from serial block face EM scans. Lodged 
HSPC is purple, surrounding EC nuclei are green and numbered. Part of the HSPC is 
missing because it was not captured in serial EM sections. (F,G) High resolution EM 
sections with cells of interest outlined as follows: EC (dark green, bright green, blue, 
light blue, yellow, orange); HSPC (purple); FB (fibroblastic mesenchymal cell; white); 
RBC (red blood cell; red). (F) Direct contact between the midsection of the pink HSPC 
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and dark green EC is visible. (G) Gaps are visible between the HSPC and surrounding 
cells. There are some contacts with the fibroblastic mesenchymal cell (FB; white). This 
FB cell does not have the melanophore inclusions observed in Embryo 1 (Figure S4G and 
data not shown; compare to Figure 4D). There are no stromal cells visible in this 
example. For 3D reconstruction see Movie S4. Scale bars: 5 microns. 
 
Figure S5. Embryonic expression patterns of CXCR4-CXCL12 homologs in 
zebrafish and dose-dependency of CXCR4 antagonist AMD3100. 
(A) Whole mount in situ expression patterns of cxcr4a, cxcr4b, cxcl12a, and cxcl12b 
between 34-38 hpf. For each example a detail of the trunk and tail is shown, with the DA 
and caudal hematopoietic tissue (CHT), respectively, marked with dashed white boxes. 
All genes are expressed in the head and lateral line. cxcr4b but not cxcr4a is expressed in 
the CHT. cxcl12a and cxcl12b are expressed in the DA and CHT. 
(B) Dose-dependent decrease in cmyb/runx1 expression levels with increasing 
concentrations of CXCR4 antagonist AMD3100. Wild-type AB embryos were treated 
from 48-72 hpf and scored as those in Figure 5A,B. The percentage of total is shown. 
 
Figure S6. Time-lapse live imaging of E11.5 fetal liver (FL) explant with labeled 
HSPC and ECs. 
(A) A time-lapse sequence from a FL lobe showing a c-kit+ HSPC (magenta) adhered to 
a CD31+ sinusoid (green). In ~30 minutes, the anterior of the cell protrudes (arrowhead) 
and extravasates to the abluminal side of the sinusoid (division marked by dotted line). 
Luminal versus abluminal sides of the sinusoid were confirmed in single z slices of 
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confocal stacks (data not shown). Scale bar: 10 microns. Times are hours:minutes after 
start of explant imaging. 
(B) After extravasation, the HSPC migrates on the abluminal side of the sinusoid. 
(C) ECs surround the HSPC as a rosette (dotted line). There is an accumulation of c-kit at 
the contact point between the HSPC and the ECs (compare to similar c-kit accumulation 
in Figure 7D,E). 
(D) A diagram summarizing the steps of HSPC lodgement in the FL. The times shown 
correspond to the time-lapse frames shown above. A morphologically symmetric division 
is observed in Figure 7D. Other possible cell division decisions are shown. 
 
Table S1. Ingenuity Pathway Analysis (IPA) of microarray data from Lycorine-
treated embryos. 
Double transgenic Runx:GFP;kdrl:RFP embryos were treated with DMSO (1%) or 
Lycorine (75 µM) from 48-72 hpf. Embryos from each pool were dissociated and sorted 
into three populations: 1) GFP+ HSPC; 2) RFP+ EC; 3) negative whole embryo. Three 
biological replicates were collected and analyzed. Lycorine-treated versus DMSO were 
compared for both HSPC and EC populations. Availabe Entrez Gene IDs were used for 
IPA analysis. (A) The Lycorine-treated EC population was enriched for genes associated 
with adhesion and extravasation. (B) The Lycorine-treated HSPC population was 
enriched for genes associated with adhesion and activation.
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Movie S1. Emergence of Runx:mCherry+ HSPC from the hemogenic endothelium 
of the DA. Corresponds to Figure S1B. Runx:mCherry+ nuclei (red) are seen in the 
kdrl:GFP+ DA (green) at ~28 hpf. The cells round up and protrude on the ventral side of 
the DA. Time-lapse live imaging captured at 2 minutes/frame and rendered at 6 
frames/second. 
 
Movie S2. HSPC niche colonization in the zebrafish CHT reveals novel steps to 
engraftment. Corresponds to Figure 3A and S3. A double transgenic embryo with 
kdrl:RFP+ ECs (red) and Runx:GFP+ HSPC (green) imaged during colonization of the 
CHT (~38-43 hpf). An arriving HSPC attaches to the endothelial wall, undergoes 
extravasation and migration to the abluminal side, followed by endothelial remodeling 
into a pocket, cell division, a 90º turn, and migration of one daughter cell out of the niche. 
Time-lapse live imaging captured at 2 minutes/frame and rendered at 6 frames/second. 
 
Movie S3. Reconstructed cells from TEM tomography are shown in relationship to 
each other in a 3D model. Corresponds to Figure 4D-F. A lodged hematopoietic 
progenitor stem cell (HSPC; purple), is closely associated with two putative stromal cells 
(light and dark blue), one of which directly contacts the HSPC. These three cells are 
nestled close to the endothelial cell wall of the dorsal aorta (individual cells outlined in 
different shades of green). Erythrocytes (red) are seen both within the dorsal aorta (as in 
Figure 4E,F upper), and in the sinusoids of the CHT in proximity to one of the stromal 
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cells (as in Figure 4E,F lower). Two additional fibroblastic mesenchymal cells with 
melanophore inclusions wrap the HSPC tightly (white and yellow). 
 
Movie S4. Reconstructed cells from TEM tomography from a second embryo are 
shown in relationship to each other in a 3D model. Corresponds to Figure S4F,G 
(Embryo 2). A lodged HSPC (purple) is closely associated with EC (dark green, bright 
green, dark blue, light blue). One EC (dark green) directly contacts the HSPC. Part of an 
RBC (red) is seen on the luminal side of an EC. Gaps are visible between the HSPC and 
surrounding cells. There are some contacts with the fibroblastic mesenchymal cell (FB; 
white) that tightly wraps the HSPC. There are no stromal cells visible in this example. 
 
Movie S5. 3D reconstruction of an HSPC surrounded by EC in an E11.5 FL. 
Corresponds to Figure 7C. A 3D rendered projection of a confocal z-stack using Volocity 
software. This example shows a Ly6a-GFP+/Runx1+ HSPC surrounded by VE-
Cadherin+ EC. Contacts with EC are visible on all sides of the HSPC. 
 
Movie S6. Time-lapse live imaging detail of an E11.5 FL explant showing EC 
remodeling around an HSPC. Corresponds to Figure 7D. A c-kit+ HSPC (magenta) 
migrates into a field of CD31+ sinusoidal ECs (green). The ECs then remodel around the 
HSPC. Maximum projection of confocal z-stack. ImageJ used for bleach correction over 
time. Time-lapse live imaging captured at 2 minutes/frame and rendered at 6 
frames/second. Times are hours:minutes after start of explant imaging. 
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Movie S7. Time-lapse live imaging detail of an E11.5 FL explant showing HSPC 
division. Corresponds to Figure 7E. A white arrowhead tracks the movement of a Ly6a-
GFP+ (green)/c-kit+(blue) HSPC that is adhered to CD31+ sinusoidal ECs (red). The 
HSPC undergoes division, with one daughter remaining surrounded by EC and the other 
migrating away. Note: Ly6a-GFP also marks some ECs and macrophages in the FL. 
Times are hours:minutes after start of explant imaging. Scale bar is 10 microns. 
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Supplemental Experimental Procedures 
 
All animals were handled according to approved Institutional Animal Care and Use 
Committee (IACUC) of Boston Children's Hospital protocols. 
 
Vectors and transgenesis 
 
All PCR was performed using the High Fidelity Advantage 2 PCR Kit (Clontech). The 
Runx1 +23 enhancer (Nottingham et al., 2007) was PCR amplified from C57/BL6 mouse 
genomic DNA using the following primers: Forward (underlined XhoI and BamHI sites 
added) 5’-GGCTCGAGGGATCCGGGGTGGGAGGTGTAAGTTC-3’ 5’-
GGGGTGGGAGGTGTAAGTTC-3’ and Reverse (underlined BglII and NotI sites 
added) 5’- GGGCGGCCGCAGATCTCAGGTGTCAGCAACCCATC -3’. The PCR 
fragment was gel purified, XhoI/BglII digested, ligated into XhoI/BamHI digested 
Tol2kit (Kwan et al., 2007) #228 p5E-MCS vector and sequence verified. The mouse !-
globin minimal promoter was PCR amplified from C57/BL6 mouse genomic DNA using 
the following primers: Forward (underlined SpeI site added) 5’-
GGACTAGTCCAATCTGCTCAGAGAGGACA-3’ and Reverse (underlined SacII site 
added) 5’-GGCCGCGGGATGTCTGTTTCTGAGGTTGC-3’. The !-globin minimal 
promoter and Runx1+23 5’ entry vector were SpeI/SacII digested and ligated together. 
Multisite Gateway reactions were performed according to the Invitrogen protocol. The 
Runx1+23 5’ entry enhancer/minimal promoter construct was assembled with middle 
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entry vectors Tol2kit #383 pME-EGFP or Tol2kit #233 pME-NLS-mCherry, 3’ entry 
vector Tol2kit #302 p3E-polyA, and destination vector Tol2kit #394 pDestTol2pA2. 
Transgenic lines were established as previously described (Mosimann et al., 2011). At 
least two independent lines with 50% transmission from the F2 generation were 
established for each construct (Runx:GFP and Runx:mCherry). 
 
Transgenic zebrafish lines 
 
We are grateful to those who generously shared the following lines for this study: 
kdrl(flk1):GFP (specifically kdrl(flk1):GRCFP (Cross et al., 2003)); kdrl(flk1):RFP 
(Huang et al., 2005); cxcl12a(sdf-1a):DsRed2 (Glass et al., 2011); cmyb:EGFP (North et 
al., 2007); cd41:EGFP (Lin et al., 2005); ubi:EGFP and ubi:mCherry (Mosimann et al., 
2011). 
 
Imaging 
 
Staged transgenic zebrafish embryos were selected and mounted for imaging in 1% LMP 
agarose with E3 media and tricaine as described (Bertrand et al., 2010). Some zebrafish 
embryos had 0.003% PTU (1-Phenyl-2-thiourea) added to the media to block 
melanogenesis. Zebrafish embryos and FL explants were imaged in MatTek glass bottom 
dishes or multi-well plates (No. 1.5 cover slip). Zebrafish live imaging was performed in 
an incubated chamber at 28°C. Mouse embryo explant live imaging was performed in an 
incubated chamber at 37°C with humidified CO2 with culture media (DMEM, 20% FCS, 
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glutamine, sodium pyruvate, 2-mercaptoethanol, 1% penicillin-streptomycin, 
recombinant mouse IL-3 (R&D Systems; final concentration 50 ng/ml)). Confocal 
microscopy was performed using a Yokogawa spinning disk and Nikon inverted Ti 
microscope. Our microscope configuration allowed imaging of multiple embryos within a 
2-5 minute interval using a moving XY stage, as well as acquisition of z-stacks through 
the entire CHT (1-2 µm optical slices) in multiple fluorescent channels. Objectives lenses 
(Nikon): 20x Plan-Apo DIC N.A. 0.75; 40x Plan-Apo phase N.A. 0.95 dry; 40x Apo 
LWD WI NA 1.15 lambda S. Image acquisition was done with a single Andor iXon DU-
897 EM-CCD camera (512x512 pixels) or dual Andor iXon x3 EM-CCD cameras 
(512x512 pixels) and Andor iQ or NIS-elements computer software. Fixed transgenic 
zebrafish embryos were scanned using a Nikon C2si confocal system and NiE upright 
microscope. These embryos were briefly fixed for 10 minutes with PEM fixation buffer 
(dH20, EGTA 10 mM, MgSO4 1 mM, PIPES 100 mM, Triton X-100 0.1%, PFA 4%; 
Cold Spring Harbor Protocols, 2009, doi:10.1101/pdb.rec11730), then washed and 
mounted with DRAQ5 (1:500) for staining of nuclei. 
 
Imaging analysis 
 
Image processing and rendering was done using Fluorender (Wan et al., 2009), Imaris 
(Bitplane), NIS-elements (Nikon), Volocity (PerkinElmer) and ImageJ/Fiji (Schindelin et 
al., 2012). The MTrackJ plugin was used for manual cell tracking (Meijering et al., 
2012). Lineage trees were created using Endrov (Henriksson et al., 2012). Point-to-point 
measurements were made with Imaris. Manual tracing, segmentation, and surface 
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rendering of objects was performed using Imaris. Confocal z-stack images are presented 
as single slices, maximum projections, or 3D rendered projections. In some cases, 
background subtraction was performed, and brightness and contrast was adjusted in one 
or more channels of a multi-channel image. 
 
Immunohistochemistry of adult WKM 
 
Adult zebrafish were fixed with 4% paraformaldehyde, paraffin-embedded, sectioned, 
and stained with hematoxylin and eosin (H&E). Immunohistochemistry was performed 
using anti-GFP monoclonal antibody (clone JL-8). The Dako Mouse Envision kit with 
EDTA antigen retrieval was used for visualization. Incubation in the primary antibody 
was 60 minutes, and 30 minutes in the secondary, followed by DAB development for 5 
minutes and counterstained with hematoxilyn. 
 
Adult-to-Adult HSPC Transplantation 
 
WKM cells from 3-month Runx:mCherry;ubi:GFP fish were isolated and sorted by 
FACS.  Double-positive cells were transplanted into irradiated casper recipients (n=20-48 
recipients per cell dose) along with untreated helper marrow at the following ratios: 
1:20,000; 5:20,000; 10:20,000; 25:20,000; 50:20,000. Transplantation procedures were 
performed as previously described (Pugach et al., 2009). At 3 months post-transplant, 
WKM from recipient fish was collected and analyzed by FACS to detect chimerism 
levels of mCherry and GFP-positive cells in the marrow.  We confirmed multi-lineage 
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reconstitution by observing differentiated GFP-positive cells in multiple cell populations, 
as determined by forward and side scatter profiles (Traver et al., 2003). Stem cell 
frequency was determined using ELDA software (confidence interval=0.95; (Hu and 
Smyth, 2009)). 
 
Embryo-to-Embryo HSPC Transplantation 
 
Adapted from previously published protocols (Stachura and Traver, 2011; Traver et al., 
2003). Runx:mCherry;ubi:EGFP or Runx:GFP;ubi:mCherry 3 dpf embryos were 
collected and chopped finely with a razor blade. Embryos were dissociated in a 1:65 
dilution of Liberase TM (Roche) in PBS, incubated at 37°C for 20 minutes before 
addition of PBS/5% FCS to stop the reaction. Dissociated cells were passed through a 45 
µM filter, spun, and resuspended in PBS/5% FCS. mCherry+/GFP+ cells were collected 
using a FACSAria cell sorter (BD Biosciences). Collected cells were resuspended in PBS 
at an estimated concentration of 400 cells/microliter with 0.5% rhodamine-dextran(10k) 
as a marker for injection. A microinjection needle (without filament) was back-filled with 
the cell suspension. The drop volume was calibrated to 1 nanoliter and each embryo was 
injected with 1, 2, or 4 drops. This gave an estimated cell dose of 0.4, 0.8 or 1.6 cells per 
embryo. Drops were injected into the sinus venosus (i.e. duct of Cuvier) of 48 hpf wild-
type AB embryo recipients. Embryos were held in place using agarose injection ramps. 
Approximately 30 embryos were injected per dose and 12-26 embryos per group survived 
to adulthood (3-5 months). WKM was then analyzed for percentage of engrafted Runx+ 
cells using a LSR II flow cytometer (BD Biosciences). Any recipients with positive cells 
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detected above background were scored as engrafted. Flow cytometry data was analyzed 
using FACSDiva and FlowJo software. 
 
Serial block face scanning electron microscopy and 3D reconstructions 
 
Immediately at the end of live imaging time-lapse acquisition 60 hpf embryos were fixed 
in 2.5% glutaraldehyde and 4% paraformaldehyde in a 0.1 M sodium cacodylate buffer. 
Embryos were embedded in 5% low melting point agarose in 0.1M sodium cacodylate 
buffer for orientation. Samples were submitted to Renovo Neural Inc (Cleveland, USA) 
for further processing. Samples were stained with heavy metals following the protocol by 
Deerinck et al., 2010 (available from the National Center for Microscopy and Imaging 
Research; http://ncmir.ucsd.edu/sbfsem-protocol.pdf). Samples were embedded in Epon 
resin, and mounted onto pins (detailed protocol available from Renovo Neural). Serial 
blockface images (analogous to serial sectioning) were obtained using a Zeiss Sigma VP 
scanning electron microscope equipped with a Gatan 3View in-chamber ultramicrotome. 
A series of 500-1000 images were acquired at 2 kV using at 15,000 magnification from 
the region of interest. Image and stack resolution was 10 nm/pixel with 100 nm slices. 
Images were registered and resized as necessary using ImageJ/Fiji software (Schindelin 
et al., 2012). Images were imported into the program IMOD 4.5 (Kremer et al., 1996) 
then aligned and reconstructed using dual-axis tomography (Mastronarde, 1997). Cells 
were manually outlined and 3D reconstructions were generated. Movies were rendered 
using IMOD and Fiji. 
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Chemicals 
 
Chemical screening was adapted from previously published methods in our lab (Kaufman 
et al., 2009; North et al., 2007; White et al., 2011). For chemical screening, stage-
matched AB embryos were dechorionated and arrayed 8-10/well in 96-well mesh-
bottomed plates (Millipore). Embryos were treated with individual library chemicals 
(~2400 bioactives) from 48-72 hpf by placement directly in 96-well receiver plates 
containing small molecules diluted in E3 media + 1% DMSO (typical concentration 30 
µM). After treatment and before fixation, we checked for secondary defects (e.g. stopped 
circulation, toxicity, developmental delay). WISH was performed as previously described 
(Thisse and Thisse, 2008), except 0.2% glutaraldehyde was added to 4% formaldehyde at 
the post-fixation step. Chemicals used in the study were as follows: AMD3100 (Sigma 
#A5602, optimal concentration 25 µM in dH2O, (Schols et al., 1997)); SB-431542 
(Sigma #S4317, optimal concentration 40 µM in DMSO, (Inman et al., 2002)); Lycorine 
(Sigma #L5139, concentration between 25-75 µM in DMSO). 
 
Microarrays 
 
Runx:GFP;kdrl:RFP embryos were collected and raised in E3 media at 28.5C. Embryos 
were treated from 2-3 dpf with E3/1% DMSO or E3/1%DMOS/75 uM Lycorine (~100-
150 embryos per group). Embryos were dissociated and sorted as above. Three 
populations were collected: GFP+ HSPC (~1-2k cells/experiment), RFP+ EC (~10-20k 
cells/experiment), and negative cells (~100k cells/experiment; total embryo as a 
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comparator population). In total, 18 samples were collected: 3 biological replicates x 2 
treatment conditions x 3 cell populations. Cells were sorted directly in Trizol LS. Trizol 
extraction was performed as per the manufacturer's instructions, with the addition of 
GenElute LPA (Sigma, Cat.#56575). Total RNA was amplified and labeled using the 
NuGEN Ovation Pico WTA System V2 and Encore Biotin Module kits, respectively. 
Affymetrix ZebGene-1_0-st microarrays were hybridized, washed, and stained using 
Ambion kits. Microarrays were scanned using the Genechip Scanner 3000 7G. 
 
All ZebGene-1_0-st array data was processed using the BioConductor (Gentleman et al., 
2004) package oligo (Carvalho and Irizarry, 2010). Arrays were assessed for quality with 
arrayQualityMetrics (Kauffmann et al., 2009) and normalized using the Robust Multichip 
Average (RMA, (Bolstad et al., 2003)) method at the probe level, collapsing probes into 
"core" transcripts based on the pd.zebgene.1.0.db annotation package (Benilton Carvalho. 
pd.zebgene.1.0.st: Platform Design Info for Affymetrix ZebGene-1_0-st. R package 
version 3.8.0.).  Batch correction was performed with the sva (Leek et al., 2012) package 
and the ComBat method (Johnson et al., 2007). Control probes and those with either 
mean log transformed intensity values of less than 2.5 or standard deviations of less than 
0.1 among all samples were removed. Probes were assigned to genes using Netaffx (Liu 
et al., 2003) annotations (ZebGene-1_0-st-v1.na33.3.zv9.transcript.csv); probes were not 
combined at the gene level, but were treated as independent assays. Differential 
expression statistics for pairwise and three-way (interaction terms) comparisons were 
generated by linear model for microarray data analysis (limma) (Smyth, 2004) using 
empirical Bayes shrinkage methods. Differentially expressed genes were assessed as 
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those with least a log fold expression change of 1 and an FDR (Benjamini and Hochberg, 
1995) based adjusted p-value of less than 0.25. Genes annotated with a zebrafish Entrez 
Gene ID were used for “Ingenuity Pathway Analysis” (IPA; QIAGEN, 
www.qiagen.com/ingenuity). 
 
Fetal liver preparations 
 
Live fetal liver explants:  Pregnant wild-type C57/BL6 and Ly6a-GFP mice were 
dissected at E11-11.5 (vaginal plug observation was E0). Embryos were removed from 
the uterus in PBS with 10% FCS and penicillin-streptomycin. Embryos were staged as 
E11-E11.5 by counting >42 somite pairs. FLs were removed from the embryo and treated 
as described by Boisset and colleagues (“protocol b”) (Boisset et al., 2010). Conjugated 
antibodies used for detection were CD31-FITC (PECAM-1, BD Biosciences, Rat anti-
mouse, clone MEC 13.3) and c-kit-APC (CD117, BD Biosciences, Rat anti-mouse, clone 
2B8). 
 
Fixed fetal livers:  Embryos were dissected as above and fixed in 2% PFA on ice for 20 
minutes. Embryos were then rinsed and dehydrated in methanol. FLs were removed, 
mounted, cleared and imaged using the method by Yokomizo et al. (Yokomizo et al., 
2012). Livers from E11.5 Ly6a-GFP mice were stained with rat anti-CD144, rabbit anti-
RUNX1, and chicken anti-GFP. Primary and secondary antibody details are below. 
Specimens were scanned using a Zeiss LSM 710 confocal microscope with a 25x oil 
objective. Images were acquired using multi-track sequential mode and Zeiss Zen 
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software. Pinhole was set at 1 Airy unit, steps were 1.14 !m per z-section. 3D projections 
were made using Volocity software. 
 
Primary antibodies: anti-CD144 (VE-cadherin) (BD Pharmingen, Catalog# 550548, 
Clone: 11D4.1, Isotype: Rat IgG2a, "); anti-RUNX1 rabbit (Abcam, Catalog# ab92336, 
Clone # EPR3099); anti-GFP Chicken IgY (Invitrogen/Life technologies, Catalog# 
A10262). 
 
Secondary antibodies: Goat Anti-Rabbit IgG (H+L) Alexa Fluor® 488 (Invitrogen/Life 
technologies, Catalog# A-11034); Goat Anti-Rabbit IgG (H+L) Alexa Fluor® 647 
(Abcam, Catalog# 150079); Goat Anti-Chicken IgY (IgG) (H+L) Alexa Fluor® 647 
(Jackson, Catalog# 103-605-155); Goat Anti-Rat IgG (H+L) Alexa Fluor® 555 (Abcam, 
Catalog# ab150158); Goat anti-chicken IgG (H+L) Alexa Fluor® 488 (Invitrogen/ Life 
Technologies, Catalog# A11039). 
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